amphetamine has been researched along with methylphenidate in 413 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 185 (44.79) | 18.7374 |
| 1990's | 18 (4.36) | 18.2507 |
| 2000's | 77 (18.64) | 29.6817 |
| 2010's | 109 (26.39) | 24.3611 |
| 2020's | 24 (5.81) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, DE; Marriott, JG; Poschel, BP | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Davydova, ON; Krendal', FP; Kudrin, AN | 1 |
| Denber, HC | 1 |
| Ferris, RM; Tang, FL | 1 |
| Brown, WA; Corriveau, DP; Ebert, MH | 1 |
| Roussinov, K; Yonkov, D | 1 |
| Debackere, M; Delbeke, FT | 1 |
| Clemens, JA; Fuller, RW | 1 |
| Browne, RG; Segal, DS | 1 |
| Boeck, V; Christensen, AV; Danneskiold-Samsoe, P; Hyttel, J; Langeland, J; Nielsen, IM; Pedersen, V; Svendsen, O | 1 |
| Gregory, EA; Price, PJ; Skeen, PC | 1 |
| Barkley, RA | 1 |
| Allen, RP; Covi, L; Safer, D | 1 |
| Arnold, LE; Huestis, RD; Smeltzer, DJ | 1 |
| Gross, MD | 1 |
| Dawsey, WJ; Geyer, MA; Mandell, AJ | 1 |
| Bradford, T; Raskind, M | 1 |
| Kuczenski, R; Segal, DS | 4 |
| Janda, R; Kaistha, KK; Tadrus, R | 1 |
| Bej, AJ; Tanner, NS; Wolters, RJ | 2 |
| Devis, D | 1 |
| Butz, R; Leitenberg, H; Peyser, J; Stableford, W | 1 |
| Remschmidt, H; Schulz, E | 1 |
| Kayser, HG | 1 |
| Lange, KW | 1 |
| Applegate, CD; Kuczenski, R; Leith, NJ; Segal, DS | 1 |
| Guze, BH; Gwirtsman, HE | 1 |
| Buda, M; Gonon, FG; Suaud-Chagny, MF | 1 |
| Hechtman, L | 1 |
| Beuthin, FC; Louis-Ferdinand, RT; Rosen, JB; Young, AM | 1 |
| Chiarello, RJ; Cole, JO | 1 |
| Corson, EO; Corson, SA | 1 |
| Barnett, JV; Kuczenski, R | 1 |
| Jones, RS; Olpe, HR; Steinmann, MW | 1 |
| Gawin, FH | 1 |
| Goldschlager, N; Lam, D | 1 |
| Little, KY | 1 |
| Collin, AK; Sharp, T; Ungerstedt, U; Zetterström, T | 1 |
| Eichlseder, W | 1 |
| Kolta, MG; Shreve, P; Uretsky, NJ | 1 |
| Giurgea, C; Leemans, R; Mouravieff-Lesuisse, F | 1 |
| Kinsbourne, M | 1 |
| Millichap, JG | 2 |
| Sroufe, LA; Stewart, MA | 1 |
| Handley, SL; Sayers, AC | 1 |
| Moore, KE; Thornburg, JE | 1 |
| Hasselager, E; Scheel-Krüger, J | 1 |
| Lipton, MA | 1 |
| Georgi, H; Gey, KF | 1 |
| Martorano, J; Rosen, S | 1 |
| Livingstone, D | 1 |
| Costall, B; Naylor, RJ | 2 |
| Carskadon, M; Dement, WC; Guilleminault, C | 1 |
| Angrist, B; Gershon, S | 1 |
| Boldrey, EE; Millichap, JG | 1 |
| Beckett, AH; Moffat, AC; Tucker, GT | 1 |
| Machata, G | 1 |
| Alfes, H; Jantos, N; Möllmann, H; Pagnucco, R; Reisch, J | 1 |
| Berstein, BM; Latimer, CN | 1 |
| Busca, GP | 1 |
| Diversi, G; Gallizia, G | 1 |
| Vinar, O | 1 |
| Alfes, H; Möllmann, H; Reisch, J | 1 |
| Fog, R | 2 |
| Dominic, JA; Moore, KE | 1 |
| Freedman, PE; Rosen, AJ | 1 |
| Chiba, S; Nagawa, Y; Yui, T | 1 |
| Carr, LA; Moore, KE | 1 |
| Delver, A; van Riezen, H | 1 |
| Allen, LE; Ferguson, HC; McKinney, GR | 1 |
| Schuster, CR; Wilson, MC | 1 |
| Davis, JM; El-Yousef, MK; Janowski, DS | 1 |
| Davis, JM | 1 |
| Fjalland, B | 1 |
| Miller, E; Nieburg, HA | 1 |
| DeLong, AR | 1 |
| Erenberg, G | 1 |
| Omenn, GS | 1 |
| Wender, PH | 1 |
| Davis, JM; Janowsky, DS | 1 |
| Patel, AN | 1 |
| Blaisdell, FW; Maxwell, TM; Olcott, C | 1 |
| Christensen, AV; Pedersen, V | 1 |
| Hasse, HE; Schönhöfer, PS; Waldmann, H | 1 |
| Connor, JD; Pardridge, WM | 1 |
| Reece, RM | 1 |
| Cashin, CH; Sutton, S | 1 |
| Idanpaan-Heikkila, J | 1 |
| Hrbek, J; Komenda, S; Medek, A; Navrátil, J | 1 |
| Chapel, JL | 1 |
| Verret, S | 1 |
| Bhagat, B; Wheeler, N | 1 |
| Foley, A; Murray, TJ | 1 |
| Cohen, JL; Cohen, SN | 1 |
| Peters, JE | 1 |
| Fjalland, B; Moller Nielsen, I; Nymark, M; Pedersen, V | 1 |
| Goldberg, AM; Silbergeld, EK | 2 |
| Fowler, GW; Millichap, JG | 1 |
| Barkai, A | 1 |
| Lingjaerde, O | 1 |
| Gershon, S; Wallach, MB | 1 |
| Ferris, RM; Maxwell, RA; Tang, FL | 1 |
| McCabe, ER; McCabe, L | 1 |
| Howell, MC; Rever, GW; Rutledge, A; Scholl, ML; Trowbridge, F | 1 |
| Jacobs, D | 1 |
| Arnold, LE; Turner, EJ | 1 |
| Levy, HB; Tec, L | 1 |
| Lotti, DM; Stewart, JT | 1 |
| Conners, CK | 1 |
| Battegay, R; Ladewig, D | 1 |
| Lal, H; O'Brien, J; Puri, SK | 1 |
| Sayers, A; Spencer, PS | 1 |
| Bejerot, N | 1 |
| Keiper, RR | 1 |
| Anggård, E; Hankey, A | 1 |
| Gordon, AM | 1 |
| Perman, ES | 1 |
| Retterstol, N | 1 |
| Schulze, HA | 1 |
| Dhawan, BN; Srimal, RC | 1 |
| Mandell, GH; Shalev, J; Sugar, HS | 1 |
| Herr, F; Voith, K | 1 |
| Oettinger, L | 1 |
| Joiris, D; Ourth, H; Périkel, JJ; Richelle, M | 1 |
| Laplace, JP; Ruckebusch, Y | 1 |
| Burgison, RM; Dietz, AJ | 1 |
| Marriott, AS | 1 |
| Grosjean, MH; Noirfalise, A | 1 |
| McNair, FE | 1 |
| Debackere, M; Eberhardt, H | 1 |
| van Zwol, DE | 1 |
| von Kerékjártó, M | 1 |
| Bartholomew, AA; Reynolds, WS | 1 |
| Fung, YK; Uretsky, NJ | 2 |
| Demarest, KT; Lawson-Wendling, KL; Moore, KE | 1 |
| Hartley, LR | 1 |
| Holloway, WR; Thor, DH | 1 |
| Ellinwood, EH; Gonzalez, LP | 1 |
| Janowsky, DS; Koob, GF; McMaster, SB; Moss, DE | 1 |
| Hirabayashi, M; Mesaki, T; Okada, S; Tadokoro, S | 1 |
| Dougherty, GG; Ellinwood, EH; Gonzalez, AE | 1 |
| Barrett, RJ; Leith, NJ | 1 |
| Ferris, SH; Gershon, S; Reisberg, B | 1 |
| Clark, WG; Clark, YL | 1 |
| Berger, PA | 1 |
| Gloyd, JS | 1 |
| Heffner, TG; Stricker, EM; Zigmond, MJ | 1 |
| Breese, GR; Kilts, CD; Patrick, KS | 1 |
| Boulton, AA; Dyck, LE; Jones, RS | 1 |
| Bonnet, JJ; Costentin, J; Héron, C | 1 |
| Dorris, RL; Truong, V | 1 |
| Dressler, D; Thiel, A | 1 |
| Davidson, ES; McNamara, CG; Schenk, S | 1 |
| Dunnick, JK; Elwell, MR; Haseman, JK | 1 |
| Hou, Y; Jouvet, M; Lin, JS | 1 |
| Grłnvald, FC; Hansen, JB; Nielsen, EB; Scheideler, M; Swedberg, MD | 1 |
| Barker, EL; Blakely, RD; Danek, KS; Justice, JB; Kable, JW | 1 |
| Madras, BK; Seeman, P | 1 |
| Deutsch, H; Schenk, JO; Schweri, MM; Wayment, HK | 1 |
| McDougall, SA; Nazarian, A; Rodarte-Freeman, AL | 1 |
| Matsuoka, H; Numachi, Y; Sato, M; Yoshida, S | 1 |
| Baldessarini, RJ; Fisser, R; Kula, NS; Neumeyer, JL; Tarazi, FI; Trometer, J; Wang, S | 1 |
| Fogle, CM; Mayorga, AJ; Paule, MG; Popke, EJ | 1 |
| Garåsen, H; Grov, B; Vik, T | 1 |
| Sund, AM; Zeiner, P | 1 |
| Grieb-Neff, P; Hart, T; Vaccaro, M; Whyte, J | 1 |
| Madras, BK; Miller, GM; Norton, C; Yatin, SM | 1 |
| Zetterström, R | 1 |
| Robbins, TW | 1 |
| Caron, MG; Jacobsen, JP; Nehrenberg, DL; Trinh, JV; Wetsel, WC | 1 |
| Richer, E; Tell, L | 1 |
| Bohn, AM; Khodaee, M; Schwenk, TL | 1 |
| DAVIS, GD | 1 |
| COLE, J; GLEES, P | 1 |
| ALEMA, G; SERGIO, C | 1 |
| LEAKE, CD | 1 |
| ARRIGONI-MARTELLI, E; BISIANI, M; GENOVESE, E | 1 |
| ARRIGONI-MARTELLI, E; GENOVESE, E; GOLDWURM, GF | 1 |
| BOIS, P; JASMIN, G | 1 |
| O'NEILL, D | 1 |
| KELLEY, NM; ROSZKOWSKI, AP | 1 |
| ARIENS, EJ; HURKMANS, JA; van der SCHOOT, J; van ROSSUM, J | 1 |
| COPPOCK, HW; HUARD, DV; MEEKS, WA | 1 |
| DECAROLIS, V; FAZIO, C; GIBERTI, F; ROSSI, R | 1 |
| CRUMP, GP | 1 |
| FITZLOFF, J; PLOTNIKOFF, NP | 1 |
| SCHMITT, H | 2 |
| MOTL, O; VOLICER, L | 1 |
| DIPALMA, JR; ROSENTHALE, ME | 1 |
| GROSSMANN, V; MRAZOVA, J; VESELY, C | 1 |
| DROOBY, AS | 1 |
| ADRIANI, J; MULLEN, J | 1 |
| SIEGLER, PE | 1 |
| BASTECKY, J | 1 |
| DANDIYA, PC; MENON, MK | 1 |
| GROSS, MD; WILSON, WC | 1 |
| FELLNER, CH | 1 |
| STEVENS, JD | 1 |
| DOBKIN, AB; EVERS, W; MALIK, K | 1 |
| RUDOLPH, AS; SEWELL, HH; WHITE, RP | 1 |
| GOKHALE, SD; GULATI, OD; JOSHI, NY | 1 |
| KARLI, P | 1 |
| Dafny, N; Swann, AC; Yang, PB | 1 |
| Janowsky, DS | 1 |
| Carboni, E; Di Chiara, G; Silvagni, A; Valentini, V | 1 |
| Avale, ME; Falzone, TL; Gelman, DM; Grandy, DK; Low, MJ; Rubinstein, M | 1 |
| Choong, KC; Shen, RY | 1 |
| Biederman, J; Spencer, T; Wilens, T | 1 |
| Bizarro, L; Murtagh, C; Patel, S; Stolerman, IP | 1 |
| Carboni, E; Silvagni, A | 1 |
| Carlson, PJ; Merlock, MC; Suppes, T | 1 |
| Boutrel, B; Koob, GF | 1 |
| Handen, B; Hardan, A; Jou, R | 1 |
| Dodson, WW | 1 |
| Quinn, PO | 1 |
| Dafny, N; Martínez-Peña, JL; Prieto-Gómez, B; Reyes-Vázquez, C; Vázquez-Alvarez, AM; Yang, PB | 1 |
| Chen, R; Gu, HH; Han, DD | 1 |
| Dougherty, M; McDonnell, MA | 1 |
| Ehrlich, ME; Niculescu, M; Unterwald, EM | 1 |
| Kitayama, S; Sogawa, C | 1 |
| Franco, K; Samuels, JA; Sorof, JM; Wan, F | 1 |
| Alexoff, DL; Dewey, SL; Fowler, JS; Logan, J; Schiffer, WK; Volkow, ND | 1 |
| Aring, E; Grönlund, MA; Hellström, A; Landgren, M | 1 |
| Abikoff, HB; Arnold, LE; Conners, CK; Elliott, G; Epstein, JN; Greenhill, LL; Hechtman, L; Hervey, AS; Hinshaw, SP; Hoagwood, K; Hoza, B; Jensen, PS; March, JS; Newcorn, JH; Pelham, WE; Severe, JB; Swanson, JM; Tonev, ST; Vitiello, B; Wells, K; Wigal, T | 1 |
| Waldron, T | 1 |
| Langendijk, PN; Wilde, AA | 1 |
| Alexander, M; Anderson, DW; Chen, MK; Decamp, E; Fritz, S; Gonczi, H; Guilarte, TR; Koser, AJ; McGlothan, JL; Rohde, CA; Schneider, JS; Syversen, T; Verina, T; Wong, DF; Zhou, Y | 1 |
| Cox, DJ; Kovatchev, B; Merkel, RL; Moore, M; Muller, C; Thorndike, F | 1 |
| Beaulieu, JM; Caron, MG; Gainetdinov, RR; Sotnikova, TD | 1 |
| Ramanujapuram, S; Surratt, CK; Ukairo, OT | 1 |
| Föhr, J; Haukka, J; Kuikanmäki, O; Kuoppasalmi, K; Meririnne, E; Sokero, P; Tiihonen, J; Tuomola, P; Vorma, H | 1 |
| Frey, BN; Inácio, CG; Kapczinski, F; Martins, MR; Quevedo, J; Réus, GZ; Schimidtz, F; Valvassori, SS | 1 |
| Fleckenstein, AE; Hanson, GR; Riddle, EL | 1 |
| Allen, AJ; Bangs, ME; Cherlin, EA; Duesenberg, DA; Feldman, PD; Kelsey, DK; Quintana, H; Ramsey, JL | 1 |
| Goodman, DW | 1 |
| Asheim, H; Furu, K; Johansen, K; Nilsen, KB | 1 |
| Gualtieri, CT; Johnson, LG | 1 |
| Ciccone, P; Gu, J; Parasrampuria, DA; Schoedel, KA; Schuller, R; Sellers, EM; Silber, SA | 1 |
| DeVane, CL; Donovan, JL; Gibson, BB; Jiang, Y; Markowitz, JS; Wang, JS; Zhu, HJ | 1 |
| Steiner, H; Yano, M | 1 |
| Fagel, DM; Maragnoli, ME; Müller Smith, K; Ohkubo, Y; Picciotto, MR; Rabenstein, RL; Schwartz, ML; Stevens, HE; Vaccarino, FM | 1 |
| Bucher, RH; Coleman, JJ; Dupont, RL; Wilford, BB | 1 |
| Kollins, SH | 1 |
| Burket, R; Cox, DJ; Kovatchev, B; Merkel, RL; Mikami, AY; Moore, M | 1 |
| Adler, LA; Michelson, D; Moore, RJ; Spencer, TJ; Williams, DW | 1 |
| Heal, DJ; Kulkarni, RS; Rowley, HL; Smith, SL | 1 |
| Swanson, JM; Volkow, ND | 1 |
| Bardo, MT; Perry, JL; Stairs, DJ | 1 |
| Biederman, J; Faraone, SV; Morley, CP; Spencer, TJ | 1 |
| Blakely, RD; Bowton, E; Freissmuth, M; Galli, A; Holy, M; Mazei-Robison, MS; Schmudermaier, M; Sitte, HH | 1 |
| Dahlström, K; Thorell, LB | 1 |
| Fischer, J; Gibbons, JA; Isdahl, WM; Ramsey, CS; Werchan, PM | 1 |
| Stein, MA | 1 |
| Bate, S; Bull, S; Dawson, LA; Hutcheson, DM; Jones, DN; Lacroix, LP; Martyn, AJ; Reavill, C; Valerio, E; Waters, KA; Woolley, ML | 1 |
| González, MA; Patrick, KS; Perkins, JS; Straughn, AB | 1 |
| Maltezos, S; Paliokosta, E; Thomson, A; Xenitidis, K | 1 |
| Marcus, S; Olfson, M; Wan, G | 1 |
| Bermeo, C; Grandy, DK; Rubinstein, M; Suchland, KL; Thanos, PK; Volkow, ND; Wang, GJ | 1 |
| Haile, CN; Kosten, TA; Kosten, TR | 1 |
| Dopheide, JA; Pliszka, SR | 1 |
| Gerhard, T; Saidi, A; Shuster, J; Winterstein, AG | 1 |
| Clement, HW; Gebhardt, S; Heiser, P; Krieg, JC; Schmidt, AJ; Schulz, E | 1 |
| Biegon, A; Brodski, C; Kofman, O; Livneh, U; Nashelsky, L; Rehavi, M; Roz, N; Sillaber, I; Tilleman, H | 1 |
| Cheetham, SC; Heal, DJ; Smith, SL | 1 |
| Dussault, C; Janusis, G; Lopes, J; Paquin, G; Varejao, M; Verdi, G; Weyandt, LL; Wilson, KG | 1 |
| Kuchibhatla, A; Merkel, RL | 1 |
| LoVecchio, F; Ozimek, J; Sawyers, B; Thole, D | 1 |
| Ginsberg, LD; Greenbaum, M; Murphy, WR; Spencer, TJ | 1 |
| Janols, LO; Klintberg, K; Liliemark, J; von Knorring, AL | 1 |
| Burton, CL; Fletcher, PJ; Nobrega, JN | 1 |
| Froehlich, TE; McGough, JJ; Stein, MA | 1 |
| Brocia, C; Fienberg, AA; Flajolet, M; Greengard, P; Nairn, AC; Rebholz, H; Warner-Schmidt, JL; Zhou, M | 1 |
| Advokat, C | 1 |
| Parker-Kotler, C; Tran, K; Weller, EB; Weller, RA; Yu, ZJ | 1 |
| Clement, HW; Gebhardt, S; Heiser, P; Hemmeter, UM; Kircher, T; Krieg, JC; Schmidt, AJ; Schulz, E | 1 |
| Andersen, SL; Chen, YI; Choi, JK; Jenkins, BG; Ren, J; Xu, H | 1 |
| Baler, RD; Swanson, J; Volkow, ND | 1 |
| Cho, S; Cho, SC; Choi, SY; Hahm, EK; Jang, H; Jeong, J; Kang, C; Kim, BN; Kim, D; Kim, E; Kim, J; Kim, JW; Kim, MH; Mah, W; Seo, J; Shin, MS; Won, H | 1 |
| Durkin, M; Marcus, SC | 1 |
| Brams, M; Findling, RL; Jain, R; Khayrallah, M; Kollins, SH; Segal, S; Wigal, SB | 1 |
| Bardo, MT; Wooters, TE | 1 |
| Bidwell, LC; Kollins, SH; McClernon, FJ | 1 |
| Figueredo, VM | 1 |
| Boehl, PO; Comiran, E; De Boni, R; Duarte, PC; Froehlich, PE; Limberger, RP; Mariotti, KC; Pechansky, F; Souza, DZ | 1 |
| Barner, JC; Khoza, S; Oladapo, A | 1 |
| Leis, HJ; Windischhofer, W | 1 |
| Jope, RS; Mines, MA | 1 |
| Childress, AC; Sallee, FR | 1 |
| Freyberg, RJ; Freyberg, Z; Javitch, JA; Karam, CS; Karam, DS; McCabe, BD; Pizzo, AB; Yamamoto, A; Yano, H; Zhang, Y | 1 |
| Advokat, C; Baumeister, AA; Henderson, K; Pow, JL | 1 |
| Almarsdóttir, AB; Baldursson, G; Halldórsson, M; Hernández-Diaz, S; Huybrechts, KF; Jónsdóttir, S; Ólafsson, Ö; Rothman, KJ; Valdimarsdóttir, UA; Zoëga, H | 1 |
| Coghill, D; Hechtman, L; Hodgkins, P; Shaw, M | 1 |
| Breindahl, T; Hindersson, P | 1 |
| Ator, NA; Kumar, A; Riddle, MA; Soto, PL; Weed, MR; Wilcox, KM; Wong, DF; Zhou, Y | 1 |
| Faraone, SV; Fredriksen, M; Haavik, J; Halmøy, A | 1 |
| Volkow, ND | 1 |
| Buchholtz, C; Dasgupta, N; Ertischek, MD; Schnoll, SH; Sembower, MA | 1 |
| Gerlach, M; Grünblatt, E; Lange, KW | 1 |
| Brensilver, M; Heinzerling, KG; Shoptaw, S | 1 |
| Dubljević, V | 2 |
| Sandberg, A | 1 |
| Hall, W; Lucke, J; Partridge, B | 1 |
| Levy, N | 1 |
| Greely, HT | 1 |
| Forlini, C; Racine, E; Schildmann, J; Vollmann, J | 1 |
| LaBuzetta, JN | 1 |
| de Sio, FS; Faulmüller, N; Maslen, H | 1 |
| Brewer, CD; DeGrote, H | 1 |
| Flanigan, J | 1 |
| van der Eijk, Y | 1 |
| Savulescu, J | 1 |
| Cheong, JH; Dela Peña, I; Jeon, SJ; Lee, E; Noh, M; Ryu, JH; Shin, CY | 1 |
| France, CP; Henson, C; Maguire, DR; Tanno, T | 1 |
| McBurnett, K; Rugino, T; Turnbow, J; White, C; Wilens, TE; Youcha, S | 1 |
| Biederman, J; Brown, A; Faraone, SV; Lomedico, A; Makris, N; Seidman, LJ; Spencer, TJ; Valera, EM | 1 |
| Blakely, RD; Davis, GL; Gowrishankar, R; Hahn, MK; Jessen, TN; Mergy, MA; Stanwood, GD; Wright, J | 1 |
| Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET | 1 |
| Beck, O; Franck, J; Sandqvist, S; Stephanson, N | 1 |
| Andrzejewski, ME; Berridge, CW; Feit, EC; Harris, RL; McKee, BL; Spencer, RC | 1 |
| Calipari, ES; Ferris, MJ; Jones, SR; Siciliano, CA; Zimmer, BA | 1 |
| Calipari, ES; Jones, SR | 1 |
| Bagot, KS; Kaminer, Y | 1 |
| Browne, JD; Fletcher, PJ; Soko, AD | 1 |
| Azeem, MW; Biederman, J; Bourgeois, B; Gonzalez-Heydrich, J; Gumlak, S; Hickory, M; Hsin, O; Kimball, K; Mezzacappa, E; Mrakotsky, C; Rober, A; Torres, A | 1 |
| Bardo, MT; Charnigo, R; Gipson, CD; Meyer, AC; Perry, JL; Yates, JR | 1 |
| Chen, Q; D'Onofrio, BM; Larsson, H; Lichtenstein, P; Runeson, B; Sjölander, A | 1 |
| Heyd, A; Nohr, FI; Norum, J; Olsen, AI; Totth, A | 1 |
| McLennan, JD; Vallerand, IA; Wagner, DJ | 1 |
| Dahl, AA; Fredriksen, M; Haavik, J; Klungsøyr, O; Martinsen, EW; Peleikis, DE | 1 |
| Calipari, ES; Ferris, MJ; Jones, SR; Siciliano, CA | 1 |
| Bryant, S; Dawson, BL; Doyle, HH; Helton, AK; Lloyd, SA; Picou, BN; Ross, JM; Schulz, J; Shanks, RA; Tavares, C | 1 |
| Farah, MJ; Hook, CJ; Ilieva, IP | 1 |
| Bloch, MH; Cohen, SC; Coughlin, CG; Ferracioli-Oda, E; Leckman, JF; Mulqueen, JM; Stuckelman, ZD | 2 |
| Chinthapalli, K | 1 |
| Baker, LE; Quisenberry, AJ | 1 |
| Calipari, ES; Ferris, MJ; Fordahl, SC; Jones, SR; Karkhanis, AN; Weiner, JL; Yorgason, JT | 1 |
| Bickel, WK; Quisenberry, AJ; Snider, SE | 1 |
| Lachaine, J; Mathurin, K; Sikirica, V | 1 |
| Merrill, RM; Palmer, CA; Thygerson, SM | 1 |
| Aguilar, JI; Chen, A; Farino, ZJ; Fei, H; Flores, J; Freyberg, R; Freyberg, Z; Hiranita, T; Hsin, LW; Hu, G; Javitch, JA; Karam, CS; Katz, JL; Kopajtic, TA; Krantz, DE; Lin, YY; Martin, CA; McCabe, BD; Mosharov, EV; Pizzo, AB; Sames, D; Sonders, MS; Sulzer, D; Wimalasena, K; Zhang, Y | 1 |
| Bassett, D; Boyce, P; Byrow, Y; Hopwood, M; Lyndon, W; Malhi, GS; Mulder, R; Murray, G; Porter, R; Singh, A | 1 |
| Hartling, L; Nikles, CJ; Punja, S; Schmid, CH; Urichuk, L; Vohra, S | 1 |
| Hartling, L; Nikles, CJ; Punja, S; Schmid, CH; Urichuk, L; Vohra, S; Xu, D | 1 |
| Bjarnadottir, GD; Bragadottir, H; Haraldsson, HM; Johannsson, M; Magnusson, A; Rafnar, BO; Sigurdsson, E; Steingrimsson, S | 1 |
| Hauber, W; Roschlau, C; Votteler, A | 1 |
| Jain, R; Stark, JG | 1 |
| Bahmanyar, S; Furu, K; Karlstad, Ø; Kieler, H; Martikainen, JE; Pottegård, A; Zoëga, H | 1 |
| Andreasen, JT; Caballero-Puntiverio, M; Fitzpatrick, CM; Woldbye, DP | 1 |
| Bastos, ML; Branco, PS; Capela, JP; Carvalho, F; Costa, VM; Feio-Azevedo, R; Ferreira, LM; Pereira, FC | 1 |
| Cartabuke, RS; Rice, J; Tobias, JD; Tumin, D | 1 |
| Borges Dos Reis, C; Chierrito de Oliveira, D; Cristina Conegero Sanches, A; Fernandez-Llimos, F; Guerrero de Sousa, P; Maria Steimbach, L; Pontarolo, R; Tonin, FS; Virtuoso, S | 1 |
| Henning, M; Hussainy, S; Jensen, M; Ram, SS; Russell, B; Stewart, K | 1 |
| Dommett, EJ; Haensel, JX; Hetherington, L; Overton, PG; Riley, TB; Turner, AC | 1 |
| Bateman, BT; Cohen, JM; Desai, RJ; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E | 1 |
| Bateman, BT; Bröms, G; Christensen, LB; Einarsdóttir, K; Engeland, A; Furu, K; Gissler, M; Hernandez-Diaz, S; Huybrechts, KF; Karlsson, P; Karlstad, Ø; Kieler, H; Lahesmaa-Korpinen, AM; Mogun, H; Nørgaard, M; Reutfors, J; Sørensen, HT; Zoega, H | 1 |
| Cooper, WO | 1 |
| Faraone, SV | 1 |
| Calliari, A; Genovese, P; Pautassi, RM; Ruiz, P; Scorza, C | 1 |
| Casavant, MJ; Chounthirath, T; Hodges, NL; King, SA; Smith, GA; Spiller, HA | 1 |
| Javanbakht, A; Suhaiban, H | 1 |
| Locatelli, I; Lukić, P; Stuhec, M | 1 |
| Cameron, J; Harney, A; Jenner, L; Lee, NK | 1 |
| Di Miceli, M; Gronier, B; Omoloye, A | 1 |
| Castro-Alvarado, D; Dafny, N; Kharas, N; Rose, K; Yang, P | 1 |
| Dafny, N; Kharas, N; Robles, T; Sanchez, A; Yang, PB | 1 |
| Andreasen, JT; Caballero-Puntiverio, M; Dietz, AG; Grupe, M; Larsen, CW; Lerdrup, LS | 1 |
| Johansen, SS; Linnet, K; Nedahl, M | 1 |
| France, CP; Maguire, DR | 1 |
| Castro, VM; Hsu, J; Moran, LV; Ongur, D; Perlis, RH; Schneeweiss, S | 1 |
| Cortese, S | 1 |
| Connor, DF; Markowitz, JS; Stein, MA; Steingard, R; Taskiran, S | 1 |
| Colpo, GD; John, V; Rocha, NP; Sassi, KLM; Teixeira, AL | 1 |
| Andreasen, JT; Arvastson, L; Aznar, S; Caballero-Puntiverio, M; Lerdrup, LS | 1 |
| Shen, G; Shi, WX | 1 |
| Brink, P; Nielsen, J; Rohde, C; Østergaard, SD | 1 |
| Arcadepani, FB; Bisaga, A; Fidalgo, TM; Gerra, G; Levin, FR; Tardelli, VS | 1 |
| Bai, Z; Charach, A; Chojecki, D; Eagles, C; Elliott, J; Hossain, A; Hsieh, SC; Husereau, D; Johnston, A; Kelly, SE; Mamdani, M; Skidmore, B; Tsakonas, E; Wells, GA | 1 |
| Daviskiba, S; Dean, D; Kern, P; King, A; Reed, B; Rockhill, S; Vohra, V | 1 |
| Al Awami, R; Albanna, A | 1 |
| Bouyssi-Kobar, M; Norman, LJ; Sharp, W; Shaw, P; Sudre, G | 1 |
| Yechiam, E; Zeif, D | 1 |
| Smith, CR; Swortwood, MJ | 1 |
| Arkell, TR; Bradshaw, K; Downey, LA; Hayley, AC | 1 |
| Dafny, N; Kharas, N; King, N; Yang, P; Yuan, A | 2 |
| Dib, T; Elgueta-Reyes, M; Escobar, AP; Espinosa, P; Martínez-Pinto, J; Renard, GM; Riquelme, R; Sanguinetti, NK; Sotomayor-Zárate, R; Velásquez, VB | 1 |
| Gether, U; Hervig, ME; Petersen, A; Robbins, TW; Toschi, C; Vangkilde, S | 1 |
| Aparicio Arias, J; Bertaso, F; Castell, L; Cutando, L; Hervé, D; Nakamura, Y; Rulhe, C; Tarot, P; Valjent, E | 1 |
| Arvanitogiannis, A; Mac Cionnaith, CE; Pallikaras, V; Pfaus, JG; Rosales, VCF | 1 |
| Bizot, JC; Figadère, B; Konofal, E; Lecendreux, M; Lormier, AT | 1 |
| Gillies, D; Leach, MJ; Perez Algorta, G | 1 |
| Alexander, GC; Curran, JN; Moore, TJ; Wirtz, PW | 1 |
| Baumgartner, MR; Fischer, SKM; Müller, TJ; Mutschler, J; Perlov, E; Seifritz, E; Soyka, M; Tschudi, L | 1 |
| Brodersen, B; Soundy, T; Van Gerpen, S; Vik, T | 1 |
| Alexander, GD; Cavanah, LR; Goldhirsh, JL; Huey, LY; Piper, BJ | 1 |
83 review(s) available for amphetamine and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Predicting the response of hyperkinetic children to stimulant drugs: a review.
Topics: Amphetamine; Amphetamines; Child; Clinical Trials as Topic; Dextroamphetamine; Electroencephalography; Evoked Potentials; Family; Galvanic Skin Response; Humans; Hyperkinesis; Methylphenidate; Neurologic Examination; Prognosis; Psychiatric Status Rating Scales; Reflex, Pupillary; Socioeconomic Factors | 1976 |
Effects of psychostimulants on aggression.
Topics: Adolescent; Aggression; Amphetamine; Animals; Child; Dextroamphetamine; Dogs; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Hyperkinesis; Male; Methylphenidate; Psychoses, Substance-Induced; Rats; Stimulation, Chemical; Structure-Activity Relationship; Substance-Related Disorders | 1975 |
[Hyperkinetic syndrome in childhood and adolescence. Diagnosis and therapy].
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Combined Modality Therapy; Humans; Methylphenidate | 1991 |
[Narcolepsy].
Topics: Adolescent; Adult; Amphetamine; Cataplexy; Child; Clomipramine; Diagnosis, Differential; Female; Humans; Imipramine; Male; Mazindol; Methylphenidate; Narcolepsy; Phenmetrazine | 1990 |
Adolescent outcome of hyperactive children treated with stimulants in childhood: a review.
Topics: Achievement; Adolescent; Amphetamine; Antisocial Personality Disorder; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Chlorpromazine; Crime; Follow-Up Studies; Humans; Male; Methylphenidate; Social Adjustment; Stimulation, Chemical | 1985 |
The use of psychostimulants in general psychiatry. A reconsideration.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Methylphenidate; Pemoline | 1987 |
Chronic neuropharmacology of cocaine: progress in pharmacotherapy.
Topics: Amphetamine; Animals; Behavior, Animal; Cocaine; Dopamine; Humans; Methylphenidate; Psychotherapy; Reward; Self Stimulation; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
Myocardial injury associated with polysubstance abuse.
Topics: Adult; Amphetamine; Cardiomyopathies; Cocaine; Drug Synergism; Electrocardiography; Female; Heroin; Humans; Male; Methylphenidate; Middle Aged; Substance-Related Disorders; Time Factors | 1988 |
Amphetamine, but not methylphenidate, predicts antidepressant efficacy.
Topics: Amphetamine; Antidepressive Agents; Behavior; Dose-Response Relationship, Drug; Humans; Methylphenidate | 1988 |
Treating problem children with stimulant drugs.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Child Behavior Disorders; Follow-Up Studies; Humans; Hyperkinesis; Learning; Learning Disabilities; Methylphenidate; Placebos; Psychotherapy; Stimulation, Chemical; Substance-Related Disorders; Time Factors | 1973 |
Dopamine and psychotic states: preliminary remarks.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Carbon Radioisotopes; Cats; Cocaine; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Humans; Methylphenidate; Pemoline; Phenmetrazine; Pimozide; Psychoses, Substance-Induced; Psychotic Disorders; Rats; Receptors, Cell Surface; Species Specificity; Stereotyped Behavior; Thioridazine; Tyrosine | 1974 |
[Psychopharmaca in modern medicine].
Topics: Amphetamine; Antidepressive Agents; Barbiturates; Butyrophenones; Chlordiazepoxide; Chlorprothixene; Diazepam; Dibenzazepines; Guaifenesin; Hallucinogens; Humans; Hypnotics and Sedatives; Imipramine; Lithium; Lysergic Acid Diethylamide; Methylphenidate; Monoamine Oxidase Inhibitors; Oxazepam; Phenmetrazine; Phenothiazines; Phytotherapy; Piperidines; Plants, Medicinal; Psilocybin; Psychopharmacology; Rauwolfia; Reserpine; Tranquilizing Agents; Xanthenes | 1968 |
What have we learned from psychoactive drug research on hyperactives?
Topics: Amphetamine; Antidepressive Agents; Child; Clinical Trials as Topic; Evaluation Studies as Topic; Humans; Hyperkinesis; Male; Methods; Methylphenidate; Research | 1972 |
Drug therapy in minimal brain dysfunction: a commentary.
Topics: Amphetamine; Anticonvulsants; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Brain; Brain Damage, Chronic; Child; Child Behavior Disorders; Chlorpromazine; Dextroamphetamine; Humans; Learning Disabilities; Methylphenidate; Thioridazine; Tranquilizing Agents | 1972 |
On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.
Topics: Amphetamine; Animals; Basal Ganglia; Caffeine; Catalepsy; Cocaine; Compulsive Behavior; Corpus Striatum; Disease Models, Animal; Dopamine; Hippocampus; Humans; Lysergic Acid Diethylamide; Methamphetamine; Methylphenidate; Morphine; Norepinephrine; Pemoline; Phenmetrazine; Psychoses, Substance-Induced; Rats; Reserpine; Thalamus; Tranquilizing Agents | 1972 |
Genetic approaches to the syndrome of minimal brain dysfunction.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Dextroamphetamine; Diseases in Twins; Epidemiologic Methods; Humans; Intellectual Disability; Methylphenidate; Phenobarbital; Sex Factors | 1973 |
Minimal brain dysfunction in children. Diagnosis and management.
Topics: Abnormalities, Multiple; Affective Symptoms; Age Factors; Amphetamine; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Child, Preschool; Cognition Disorders; Compulsive Behavior; Family; Humans; Hyperkinesis; Infant; Interpersonal Relations; Learning Disabilities; Methylphenidate; Movement Disorders; Neurologic Manifestations; Psychological Tests | 1973 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Deanol; Humans; Learning Disabilities; Methylphenidate; Movement Disorders; Placebos; Reserpine; Tranquilizing Agents | 1967 |
[Stimulants in the treatment of hyperkinetic behavior disorders].
Topics: Amphetamine; Child; Child Behavior Disorders; Child, Preschool; Dextroamphetamine; Humans; Hyperkinesis; Methylphenidate | 1971 |
Pharmacotherapy of senile dementia.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Amphetamine; Antidepressive Agents, Tricyclic; Dementia; Depression; Dihydroergotoxine; Female; Humans; Male; Memory; Methylphenidate; Papaverine; Procaine; Pyrrolidinones; Thioridazine | 1980 |
Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants.
Topics: Amphetamine; Animals; Antidepressive Agents; Biogenic Amines; Body Temperature; Fenfluramine; Humans; Methylphenidate; Quipazine; Serotonin; Serotonin Antagonists; Sympathomimetics; Tryptamines | 1980 |
Biochemistry and the schizophrenia. Old concepts and new hypothesis.
Topics: Acetylcholine; Amphetamine; Animals; Brain; Cocaine; Dopamine; Endorphins; gamma-Aminobutyric Acid; Humans; Methylphenidate; Naloxone; Norepinephrine; Phenethylamines; Physostigmine; Schizophrenia; Schizophrenia, Paranoid | 1981 |
Anti-hyperactivity medication: methylphenidate and amphetamine.
Topics: Adult; Amino Acid Sequence; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dopamine; Humans; Methylphenidate; Models, Neurological; Molecular Sequence Data; Parkinson Disease; Protein Conformation; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Repetitive Sequences, Amino Acid; Synapses | 1998 |
[Neurotoxicity of psychostimulants].
Topics: Amphetamine; Brain; Central Nervous System Stimulants; Depression, Chemical; Dopamine; Humans; Methylphenidate; Psychoses, Substance-Induced | 1999 |
Psychostimulant use in the rehabilitation of individuals with traumatic brain injury.
Topics: Amphetamine; Brain Injuries; Central Nervous System Stimulants; Controlled Clinical Trials as Topic; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injury Severity Score; Male; Methylphenidate; Pilot Projects; Prognosis; Treatment Outcome | 2002 |
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Amphetamine; Animals; Attention; Behavior, Animal; Brain; Brain Chemistry; Choice Behavior; Clonidine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Methylphenidate; Norepinephrine; Psychomotor Performance; Reaction Time; Serotonin | 2002 |
[Indications, efficacy and tolerance of drug therapy in view of improving recovery of consciousness following a traumatic brain injury].
Topics: Amphetamine; Brain Injuries; Bromocriptine; Central Nervous System Stimulants; Coma; Consciousness; Databases, Factual; Dopamine Agonists; Humans; Methylphenidate; Neurotransmitter Agents; Persistent Vegetative State; Prognosis; Treatment Outcome | 2003 |
Ephedrine and other stimulants as ergogenic aids.
Topics: Amphetamine; Bupropion; Cocaine; Dopamine Uptake Inhibitors; Doping in Sports; Ephedrine; Humans; Methylphenidate; Sports; Sympathomimetics | 2003 |
PHARMACODYNAMIC REACTIVITY IN MENTAL PATIENTS MEASURED BY FRACTIONED "WECKANALYSE".
Topics: Amobarbital; Amphetamine; Amphetamines; Blood Pressure; Drug Tolerance; Electroconvulsive Therapy; Heart Rate; Humans; Mental Disorders; Mentally Ill Persons; Methylphenidate; Personality; Pulse | 1963 |
CURRENT STATUS OF DRUG TREATMENT IN THE DEPRESSIVE STATE.
Topics: Amitriptyline; Amphetamine; Amphetamines; Antidepressive Agents; Aspartic Acid; Benactyzine; Classification; Deanol; Depression; Desipramine; Humans; Imipramine; Isocarboxazid; Methylphenidate; Monoamine Oxidase Inhibitors; Nialamide; Pargyline; Pharmacology; Phenelzine; Phenmetrazine; Piperidines; Sympathomimetics; Toxicology; Tranylcypromine | 1964 |
PSYCHOPHARMACOLOGY.
Topics: Amphetamine; Antidepressive Agents; Drug Hypersensitivity; Drug Synergism; Methylphenidate; Phenothiazines; Psychopharmacology; Sympathomimetics; Toxicology; Tranquilizing Agents; Tranylcypromine | 1964 |
Depression and dysphoria effects on the interpersonal perception of negative and positive moods and caring relationships: effects of antidepressants, amphetamine, and methylphenidate.
Topics: Amphetamine; Antidepressive Agents; Anxiety Disorders; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder, Major; Dysthymic Disorder; Humans; Interpersonal Relations; Methylphenidate; Social Perception; Treatment Outcome | 2003 |
Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Humans; Methylphenidate; Synaptic Transmission | 2004 |
What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
Topics: Amphetamine; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitors; Humans; Methylphenidate; Modafinil; Narcolepsy; Nicotine; Sleep; Wakefulness | 2004 |
Pharmacotherapy of adult ADHD.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome | 2005 |
Righting a troubled course. Diagnosing and treating ADHD in adults.
Topics: Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Humans; Methylphenidate; Nurse Practitioners; Nursing Assessment; Practice Guidelines as Topic; Primary Health Care; Propylamines | 2005 |
Regulated expression and function of the somatodendritic catecholamine neurotransmitter transporters.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Catecholamines; Central Nervous System; Central Nervous System Stimulants; Dendrites; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Ion Channels; Methylphenidate; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins | 2005 |
The consequences of attention-deficit/hyperactivity disorder in adults.
Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Disease Progression; Female; Health Care Costs; Humans; Impulsive Behavior; Male; Mental Disorders; Methylphenidate; Propylamines; Quality of Life; Sex Distribution; Social Adjustment; Substance-Related Disorders | 2007 |
Methylphenidate and cocaine: the same effects on gene regulation?
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Gene Expression Regulation; Humans; Methylphenidate; Molecular Structure | 2007 |
ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cocaine-Related Disorders; Humans; Marijuana Abuse; Methylphenidate; Practice Guidelines as Topic; Substance-Related Disorders | 2008 |
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Humans; Methylphenidate; Microdialysis; Norepinephrine; Propylamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2008 |
Effect of stimulants on height and weight: a review of the literature.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Body Height; Body Weight; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Methylphenidate | 2008 |
Evolution of stimulants to treat ADHD: transdermal methylphenidate.
Topics: Administration, Cutaneous; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Delayed-Action Preparations; Dermatitis, Contact; Humans; Methylphenidate; Skin Absorption; Stereoisomerism; Time Factors | 2009 |
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Fragile X Syndrome; Humans; Methylphenidate; Persons with Mental Disabilities | 2009 |
Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.
Topics: Amphetamine; Amphetamine-Related Disorders; Cocaine-Related Disorders; Disulfiram; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Humans; Methamphetamine; Methylphenidate; Pharmacogenetics; Polymorphism, Single Nucleotide | 2009 |
Attention-deficit-hyperactivity disorder: an update.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Case-Control Studies; Central Nervous System Stimulants; Child; Conduct Disorder; Follow-Up Studies; Humans; Juvenile Delinquency; Longitudinal Studies; Methylphenidate; Patient Compliance; Prescriptions; Prevalence; Propylamines; Substance-Related Disorders; Time Factors; Treatment Outcome; United States | 2009 |
The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Catecholamines; Central Nervous System Stimulants; Dopamine Agents; Humans; Methylphenidate; Propylamines; Stereoisomerism; Substance-Related Disorders | 2009 |
Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
Topics: Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Child; Child, Preschool; Clinical Trials as Topic; Comorbidity; Humans; Methylphenidate; Randomized Controlled Trials as Topic; Risk; Substance-Related Disorders; Young Adult | 2009 |
Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.
Topics: Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Catechol O-Methyltransferase; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Humans; Inactivation, Metabolic; Methylphenidate; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D4; Receptors, Dopamine D5; Synaptosomal-Associated Protein 25 | 2010 |
What are the cognitive effects of stimulant medications? Emphasis on adults with attention-deficit/hyperactivity disorder (ADHD).
Topics: Achievement; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition Disorders; Humans; Methylphenidate; Neuropsychological Tests | 2010 |
Pharmacologic neuroimaging of the ontogeny of dopamine receptor function.
Topics: Adolescent; Adult; Aging; Amphetamine; Animals; Brain; Cerebrovascular Circulation; Cocaine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Magnetic Resonance Imaging; Male; Methylphenidate; Microdialysis; Phenanthridines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Regional Blood Flow | 2010 |
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.
Topics: Amphetamine; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognition; Executive Function; Humans; Impulsive Behavior; Methylphenidate; Neuropharmacology | 2011 |
Cognitive enhancers for the treatment of ADHD.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cholinergic Agents; Clonidine; Cognition; Executive Function; Guanfacine; Humans; Intelligence; Methylphenidate; Nootropic Agents; Propylamines; Reward; Social Behavior | 2011 |
Chemical cardiomyopathies: the negative effects of medications and nonprescribed drugs on the heart.
Topics: Amphetamine; Anabolic Agents; Anthracyclines; Antineoplastic Agents; Cardiomyopathies; Chloroquine; Clozapine; Cocaine; Doxorubicin; Ephedra; Ethanol; Heart; Humans; Methylphenidate; Nonprescription Drugs; Prescription Drugs; Testosterone | 2011 |
Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Amphetamine; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Clonidine; Drug Therapy, Combination; Electrocardiography; Humans; Methylphenidate; Randomized Controlled Trials as Topic | 2012 |
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Treatment Outcome | 2012 |
Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Sectional Studies; Humans; Longitudinal Studies; Methylphenidate; Propylamines; Randomized Controlled Trials as Topic | 2013 |
Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Dopaminergic Neurons; Humans; Methylphenidate | 2013 |
Pharmacotherapy of amphetamine-type stimulant dependence: an update.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Bupropion; Central Nervous System Stimulants; Humans; Methylphenidate; Naltrexone; Randomized Controlled Trials as Topic | 2013 |
Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Corpus Striatum; Gene Expression Profiling; Gene Expression Regulation; Male; Methamphetamine; Methylphenidate; Mice; Morphine; Neuronal Plasticity; Rats; Rats, Wistar; Reinforcement Schedule; Reward; Self Administration; Transcriptome | 2013 |
Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.
Topics: Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methylphenidate; Treatment Outcome; Young Adult | 2013 |
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Gene Knock-In Techniques; Humans; Methylphenidate; Mice; Mice, Neurologic Mutants; Mutation; Sensation | 2014 |
Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review.
Topics: Adolescent; Adult; Amphetamine; Attention; Benzhydryl Compounds; Central Nervous System Stimulants; Cognition; Humans; Mental Recall; Methylphenidate; Modafinil; Nootropic Agents; Problem Solving; Young Adult | 2014 |
Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis.
Topics: Amphetamine; Central Nervous System Stimulants; Executive Function; Humans; Inhibition, Psychological; Memory, Episodic; Memory, Short-Term; Methylphenidate; Publication Bias | 2015 |
Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Odds Ratio; Randomized Controlled Trials as Topic; Severity of Illness Index; Tics | 2015 |
Does impulsivity change rate dependently following stimulant administration? A translational selective review and re-analysis.
Topics: Amphetamine; Benzhydryl Compounds; Central Nervous System Stimulants; Clinical Trials as Topic; Humans; Impulsive Behavior; Methylphenidate; Modafinil | 2016 |
Stimulants for depression: On the up and up?
Topics: Amphetamine; Antidepressive Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulants; Depression; Depressive Disorder, Major; Dextroamphetamine; Drug Therapy, Combination; Humans; Methylphenidate; Modafinil; Randomized Controlled Trials as Topic | 2016 |
To meta-analyze or not to meta-analyze? A combined meta-analysis of N-of-1 trial data with RCT data on amphetamines and methylphenidate for pediatric ADHD.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Biomedical Research; Child; Child, Preschool; Female; Humans; Male; Meta-Analysis as Topic; Methylphenidate; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysis.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Female; Humans; Male; Methylphenidate; Treatment Outcome | 2016 |
Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dosage Forms; Drug and Narcotic Control; Drug Compounding; Humans; Methylphenidate; Substance-Related Disorders | 2016 |
Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Humans; Methylphenidate; Network Meta-Analysis; Odds Ratio; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Wakefulness | 2019 |
Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Irritable Mood; Methylphenidate | 2017 |
The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Comorbidity; Dopamine Uptake Inhibitors; Humans; Mental Disorders; Methylphenidate | 2018 |
Efficacy, Acceptability, and Tolerability of Lisdexamfetamine, Mixed Amphetamine Salts, Methylphenidate, and Modafinil in the Treatment of Attention-Deficit Hyperactivity Disorder in Adults: A Systematic Review and Meta-analysis.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Salts; Treatment Outcome | 2019 |
Pharmacotherapy for amphetamine dependence: A systematic review.
Topics: Amphetamine; Amphetamine-Related Disorders; Dextroamphetamine; Humans; Medication Adherence; Methylphenidate; Modafinil; Naltrexone; Randomized Controlled Trials as Topic | 2018 |
New Formulations of Stimulants: An Update for Clinicians.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Drug Administration Schedule; Humans; Methylphenidate; Tablets | 2019 |
Amphetamine Use in the Elderly: A Systematic Review of the Literature.
Topics: Aged; Amphetamine; Dementia; Depressive Disorder, Major; Humans; Lisdexamfetamine Dimesylate; Methylphenidate | 2020 |
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Topics: Amphetamine; Central Nervous System Stimulants; Cocaine; Double-Blind Method; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Modafinil; Prescription Drugs; Randomized Controlled Trials as Topic; Substance-Related Disorders; Treatment Outcome | 2020 |
Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bayes Theorem; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug-Related Side Effects and Adverse Reactions; Female; Guanfacine; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Network Meta-Analysis; Quality of Life; Randomized Controlled Trials as Topic | 2020 |
Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Humans; Impulsive Behavior; Methylphenidate | 2022 |
NLS-3 (Levophacetoperane or (
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Methylphenidate | 2024 |
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Methylphenidate; Quality of Life | 2023 |
25 trial(s) available for amphetamine and methylphenidate
| Article | Year |
|---|---|
Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate.
Topics: Adult; Amphetamine; Dextroamphetamine; Emotions; Growth Hormone; Humans; Hydrocortisone; Male; Methylphenidate; Neurosecretory Systems; Placebos; Time Factors | 1978 |
Predicting the response of hyperkinetic children to stimulant drugs: a review.
Topics: Amphetamine; Amphetamines; Child; Clinical Trials as Topic; Dextroamphetamine; Electroencephalography; Evoked Potentials; Family; Galvanic Skin Response; Humans; Hyperkinesis; Methylphenidate; Neurologic Examination; Prognosis; Psychiatric Status Rating Scales; Reflex, Pupillary; Socioeconomic Factors | 1976 |
Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: a double-blind comparison.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Caffeine; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Methylphenidate; Placebos | 1975 |
A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
Topics: Adolescent; Age Factors; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clinical Trials as Topic; Dextroamphetamine; Drug Evaluation; Humans; Hyperkinesis; Individuality; Methylphenidate | 1976 |
The use of psychostimulants in general psychiatry. A reconsideration.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Methylphenidate; Pemoline | 1987 |
Studies in hyperkinetic behavior. II. Laboratory and clinical evaluations of drug treatments.
Topics: Adolescent; Amphetamine; Animals; Anticonvulsants; Central Nervous System Stimulants; Child; Higher Nervous Activity; Humans; Locomotion; Methylphenidate; Mice; Movement Disorders; Phenobarbital; Phenytoin | 1967 |
What have we learned from psychoactive drug research on hyperactives?
Topics: Amphetamine; Antidepressive Agents; Child; Clinical Trials as Topic; Evaluation Studies as Topic; Humans; Hyperkinesis; Male; Methods; Methylphenidate; Research | 1972 |
Dopamine, psychomotor stimulants, and schizophrenia: effects of methylphenidate and the stereoisomers of amphetamine in schizophrenics.
Topics: Amphetamine; Behavior; Clinical Trials as Topic; Dextroamphetamine; Dopamine; Humans; Methylphenidate; Psychotic Disorders; Stereoisomerism; Structure-Activity Relationship | 1974 |
Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
Topics: Amphetamine; Anticonvulsants; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Clinical Trials as Topic; Deanol; Humans; Learning Disabilities; Methylphenidate; Movement Disorders; Placebos; Reserpine; Tranquilizing Agents | 1967 |
[Differences between prophylactic and therapeutic effects of stimulant drugs].
Topics: Adult; Amphetamine; Antidepressive Agents; Humans; Male; Methylphenidate; Nervous System Diseases; Placebos; Surveys and Questionnaires | 1966 |
Stimulant treatment of adult attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cross-Over Studies; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Methylphenidate; Pemoline | 2004 |
Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
Topics: Adult; Aged; Amphetamine; Antipsychotic Agents; Bipolar Disorder; Central Nervous System Stimulants; Clozapine; Consciousness Disorders; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Middle Aged; Retrospective Studies | 2004 |
Pharmacotherapy of adult ADHD.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate; Propylamines; Treatment Outcome | 2005 |
Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Central Nervous System Stimulants; Child; Cross-Over Studies; Dextroamphetamine; Double-Blind Method; Female; Humans; Male; Methylphenidate; Time Factors | 2006 |
Assessing medication effects in the MTA study using neuropsychological outcomes.
Topics: Amphetamine; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Combined Modality Therapy; Data Interpretation, Statistical; Dextroamphetamine; Female; Follow-Up Studies; Humans; Methylphenidate; Neuropsychological Tests; Normal Distribution; Pemoline; Reaction Time; Task Performance and Analysis; Time Factors; Treatment Outcome | 2006 |
Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Topics: Accidents, Traffic; Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Central Nervous System Stimulants; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Methylphenidate; Treatment Outcome | 2006 |
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Aripiprazole; Female; Humans; Male; Methylphenidate; Piperazines; Placebos; Quinolones; Severity of Illness Index; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome | 2007 |
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Amphetamine; Analysis of Variance; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Male; Methylphenidate; Pilot Projects; Propylamines; Severity of Illness Index; Treatment Outcome | 2007 |
Medications do not necessarily normalize cognition in ADHD patients.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognition; Cross-Sectional Studies; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Propylamines | 2008 |
Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
Topics: Administration, Oral; Adolescent; Adult; Amphetamine; Area Under Curve; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Male; Methylphenidate; Middle Aged; Osmosis; Substance-Related Disorders; Syncope, Vasovagal | 2007 |
Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Central Nervous System Stimulants; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Humans; Male; Methylphenidate; Time Factors | 2008 |
Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Humans; Longitudinal Studies; Methylphenidate; Patient Dropouts; Placebos; Propylamines; Psychiatric Status Rating Scales; Safety; Severity of Illness Index; Treatment Outcome | 2008 |
Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Guanfacine; Humans; Male; Methylphenidate; Psychiatric Status Rating Scales; Severity of Illness Index | 2009 |
Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
Topics: Adolescent; Adolescent Behavior; Adrenergic alpha-2 Receptor Agonists; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Behavior; Clonidine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methylphenidate; Retrospective Studies; Treatment Outcome | 2011 |
Morning and Evening Effects of Guanfacine Extended Release Adjunctive to Psychostimulants in Pediatric ADHD.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Amphetamine; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Guanfacine; Humans; Male; Methylphenidate; Parents; Schools; Treatment Outcome | 2017 |
310 other study(ies) available for amphetamine and methylphenidate
| Article | Year |
|---|---|
Cognition-activating properties of 3-(Aryloxy)pyridines.
Topics: Animals; Cognition; Dose-Response Relationship, Drug; Male; Mice; Psychotropic Drugs; Pyridines; Structure-Activity Relationship | 1981 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cardiac Glycosides; Cats; Drug Interactions; Haloperidol; Humans; Hypertension; Lithium; Methyldopa; Methylphenidate; Monoamine Oxidase Inhibitors; Parasympatholytics; Phenothiazines; Propranolol; Tranquilizing Agents | 1977 |
The pharmacologic treatment of depression.
Topics: Amphetamine; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Deanol; Depression; Dose-Response Relationship, Drug; Humans; Lithium; Methylphenidate; Monoamine Oxidase Inhibitors; Phenmetrazine; Piperidines | 1979 |
Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus.
Topics: Amphetamine; Animals; Brain; Corpus Striatum; Desipramine; Dopamine; Energy Metabolism; Hypothalamus; In Vitro Techniques; Kinetics; Male; Methylphenidate; Norepinephrine; Piperidines; Rats; Reserpine; Stereoisomerism; Synaptic Vesicles; Temperature | 1979 |
Influence of diethyldithiocarbamate (DDC) on the memory-facilitating effect of some central stimulants.
Topics: Amphetamine; Animals; Avoidance Learning; Brain Chemistry; Caffeine; Ditiocarb; Drug Interactions; Male; Memory; Methylphenidate; Norepinephrine; Quinolines; Quinolones; Rats; Strychnine; Thiocarbamates; Time Factors | 1979 |
Isolation and detection of methylphenidate, phacetoperane and some other sympatomimetic central nervous stimulants with special reference to doping. I. Gas chromatographic detection procedure with electron capture detection for some secondary amines.
Topics: Amphetamine; Benzyl Alcohols; Chemical Phenomena; Chemistry; Chromatography, Gas; Hydrogen-Ion Concentration; Hydrolysis; Mass Spectrometry; Methylphenidate; Piperidines; Sympathomimetics; Temperature | 1975 |
Differences in the effects of amphetamine and methylphenidate on brain dopamine turnover and serum prolactin concentration in reserpine-treated rats.
Topics: Amphetamine; Animals; Brain; Dopamine; Male; Methylphenidate; Prolactin; Rats; Reserpine | 1979 |
Metabolic and experimental factors in the behavioral response to repeated amphetamine.
Topics: Amphetamine; Animals; Behavior, Animal; Dextroamphetamine; Habituation, Psychophysiologic; Humans; Male; Methylphenidate; Motor Activity; Rats; Stereotyped Behavior; Time Factors | 1977 |
The pharmacology of a new potent, long acting neuroleptic, piflutixol.
Topics: Adenylyl Cyclases; Amphetamine; Anesthesia; Animals; Apomorphine; Arousal; Barbiturates; Behavior, Animal; Catalepsy; Dogs; Dopamine Antagonists; Escape Reaction; Ethanol; Female; Humans; Male; Methylphenidate; Mice; Motor Activity; Piperidines; Rabbits; Rats; Thioxanthenes; Tranquilizing Agents | 1977 |
Ritalin, Benzedrine and Dexedrine do not transform F 1706 rat cells.
Topics: Amphetamine; Animals; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Dextroamphetamine; Methylphenidate; Rats | 1978 |
Differential effects of caffeine, D-amphetamine and methylphenidate on individual raphe cell fluorescence: a microspectrofluorimetric demonstration.
Topics: Amphetamine; Animals; Caffeine; Male; Mesencephalon; Methylphenidate; Rats; Serotonin; Spectrometry, Fluorescence | 1975 |
Methylphenidate (ritalin) abuse and methadone maintenance.
Topics: Adult; Amphetamine; Atropa belladonna; Barbiturates; Diazepam; Female; Heroin Dependence; Humans; Male; Methadone; Methylphenidate; Plants, Medicinal; Plants, Toxic; Substance-Related Disorders; Washington | 1975 |
Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis.
Topics: Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Dextroamphetamine; Dopamine; In Vitro Techniques; Male; Methylphenidate; Rats; Rats, Inbred Strains; Reserpine; Synaptosomes; Tyrosine | 1975 |
Simultaneous detection of a wide variety of commonly abused drugs in a urine screening program using thin-layer identification techniques.
Topics: 1-Propanol; Ammonia; Ammonium Chloride; Amphetamine; Barbiturates; Chloroform; Chromatography, Thin Layer; Codeine; Humans; Hypnotics and Sedatives; Indicators and Reagents; Ion Exchange Resins; Methadone; Methamphetamine; Methylphenidate; Morphine; Opium; Phenmetrazine; Substance-Related Disorders | 1975 |
Conformationally constrained analogs of mescaline II.
Topics: Amphetamine; Animals; Chemical Phenomena; Chemistry; Mescaline; Methylphenidate; Molecular Conformation; Motor Activity | 1975 |
[Release of dopamine and symptoms of schizophrenia].
Topics: Amphetamine; Dextroamphetamine; Dopamine; Humans; Methylphenidate; Norepinephrine; Schizophrenia | 1975 |
Sequential withdrawal of stimulant drugs and use of behavior therapy with two hyperactive boys.
Topics: Amphetamine; Behavior Therapy; Child; Dextroamphetamine; Humans; Hyperkinesis; Male; Methylphenidate; Placebos; Reward | 1976 |
[Turnover of central nervous system stimulating drugs in Norway during the period 1980-1989].
Topics: Amphetamine; Central Nervous System Agents; Drug Utilization; Humans; Methylphenidate; Norway | 1991 |
Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Apomorphine; Brain; Haloperidol; Hydroxyindoleacetic Acid; Male; Methylphenidate; Methyltyrosines; Motor Activity; Rats; Rats, Inbred Strains; Serotonin | 1987 |
Amphetamine, but not methylphenidate, predicts antidepressant response.
Topics: Amphetamine; Antidepressive Agents; Depressive Disorder; Humans; Methylphenidate; Prognosis | 1989 |
Pharmacology of electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Apomorphine; Dopamine; Electric Stimulation; Electrochemistry; Electrodes; Haloperidol; Male; Medial Forebrain Bundle; Methylphenidate; Nomifensine; Olfactory Bulb; Rats; Reserpine; Sulpiride | 1989 |
Discriminative stimulus properties of amphetamine and other stimulants in lead-exposed and normal rats.
Topics: Amphetamine; Animals; Apomorphine; Body Weight; Caffeine; Central Nervous System Stimulants; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Lead; Lead Poisoning; Male; Methylphenidate; Rats | 1986 |
Psychopharmacologic facilitation of psychosocial therapy of violence and hyperkinesis.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Behavior Therapy; Behavior, Animal; Conditioning, Psychological; Emotions; Hyperkinesis; Isomerism; Methylphenidate; Psychotropic Drugs; Violence | 1988 |
Desensitization of rat striatal dopamine-stimulated adenylate cyclase after acute amphetamine administration.
Topics: Adenylyl Cyclases; Amphetamine; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Kinetics; Male; Methylphenidate; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Sodium Fluoride; Stereotyped Behavior; Time Factors | 1986 |
Locus coeruleus as a target for psychogeriatric agents.
Topics: Amphetamine; Animals; Caffeine; Cerebral Cortex; Dihydroergotoxine; Dose-Response Relationship, Drug; Learning; Locus Coeruleus; Male; Memory; Methylphenidate; Neural Pathways; Neurons; Piracetam; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Septum Pellucidum; Vincamine | 1985 |
In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Corpus Striatum; Dopamine; Drug Interactions; Extracellular Space; Male; Methylphenidate; Nomifensine; Phenylacetates; Potassium Chloride; Rats; Rats, Inbred Strains | 1988 |
Ten years of experience with 1,000 hyperactive children in a private practice.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Body Height; Body Weight; Child; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methylphenidate | 1985 |
Effect of methylphenidate pretreatment on the behavioral and biochemical responses to amphetamine.
Topics: Amphetamine; Animals; Brain Chemistry; Corpus Striatum; Dopamine; Exploratory Behavior; Male; Methylphenidate; Nucleus Accumbens; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1985 |
Correlations between electrical and pharmacological observations during anoxia in the rabbit, in normal and assisted respiration.
Topics: Amphetamine; Brain; Caffeine; Electroencephalography; Ethylamines; Hypoxia; Meclofenoxate; Methylphenidate; Pentylenetetrazole; Respiration; Respiration, Artificial; Theophylline | 1971 |
School problems: diagnosis and treatment.
Topics: Agnosia; Amphetamine; Anxiety; Child; Child, Preschool; Cognition Disorders; Developmental Disabilities; Dyslexia; Functional Laterality; Humans; Hyperkinesis; Impulsive Behavior; Intelligence Tests; Learning Disabilities; Methylphenidate; Neurologic Examination; Physical Examination; Psychological Tests; Schools; Serial Learning; Underachievement | 1973 |
Drugs in management of minimal brain dysfunction.
Topics: Amphetamine; Anticonvulsants; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Auditory Perception; Child; Child Behavior; Child Behavior Disorders; Child, Preschool; Deanol; Electroencephalography; Histamine H1 Antagonists; Humans; Methylphenidate; Personality Assessment; Reserpine; Tranquilizing Agents | 1973 |
A study of the role of catecholamines in the response to various central stimulants.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Catecholamines; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Drug Interactions; Ephedrine; Female; Humans; Methamphetamine; Methylphenidate; Methyltyrosines; Motor Activity; Phenmetrazine; Rats; Reserpine; Stereotyped Behavior | 1973 |
The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs.
Topics: Amphetamine; Animals; Appetite; Carbon Radioisotopes; Diet; Disulfides; Dopamine; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Imidazoles; Male; Methylphenidate; Methyltyrosines; Mice; Motor Activity; Neurons; Norepinephrine; Phenmetrazine; Piperidines; Stimulation, Chemical; Thiazoles; Thiourea; Time Factors | 1973 |
Drugs in the management of learning and behavior disorders in school children.
Topics: Amphetamine; Anticonvulsants; Child; Child Behavior Disorders; Humans; Learning Disabilities; Methylphenidate; Tranquilizing Agents | 1974 |
Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain; Brain Chemistry; Carboxylic Acids; Chromatography, Ion Exchange; Clonidine; Fever; Hydroxyindoleacetic Acid; Male; Methylphenidate; Naphthyridines; Phenmetrazine; Piperidines; Rats; Serotonin; Spectrometry, Fluorescence; Temperature | 1974 |
Neuropsychopharmacology of monoamines and their regulatory enzymes.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Biogenic Amines; Brain; Cocaine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dopamine beta-Hydroxylase; Humans; Isoenzymes; Methylphenidate; Monoamine Oxidase; Neurons; Norepinephrine; Phenylethanolamine N-Methyltransferase; Schizophrenia; Serotonin; Tyrosine; Tyrosine 3-Monooxygenase | 1974 |
Effect of neurotropic agents on total pyridoxal phosphate and on the activity of the decarboxylose of aromatic amino acids as well as of other pyridoxal phosphate-dependent enzymes in rat brains.
Topics: Acetates; Amphetamine; Animals; Anti-Anxiety Agents; Atropine; Benzodiazepines; Brain; Carbon Radioisotopes; Carboxy-Lyases; Chloroform; Chlorpromazine; Cocaine; Dihydroxyphenylalanine; Ether; Female; Glutamates; Haloperidol; Hydroxylamines; Methylphenidate; Oxotremorine; Pentobarbital; Pentylenetetrazole; Pyridoxal Phosphate; Quinolines; Rats; Reserpine; Scopolamine; Semicarbazides; Theophylline; Tranylcypromine; Tyrosine Transaminase | 1974 |
Clinical application of antidepressant agents in disabled and rehabilitation patients.
Topics: Aged; Amitriptyline; Amphetamine; Antidepressive Agents; Depression; Disabled Persons; Hemiplegia; Humans; Imipramine; Male; Methylphenidate; Middle Aged; Monoamine Oxidase Inhibitors; Rehabilitation; Tranquilizing Agents | 1965 |
Some general observations on the usefulness of lysergic acid in psychiatry.
Topics: Amobarbital; Amphetamine; Drug Synergism; Humans; Lysergic Acid Diethylamide; Mental Disorders; Methylphenidate; Niacinamide; Pulse | 1966 |
Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Dioxoles; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Humans; Injections; Male; Methylphenidate; Motor Activity; Nialamide; Piperazines; Pyrimidines; Rats; Stereotyped Behavior; Sulfites | 1974 |
On the treatment of rapid eye movement narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Depression; Desipramine; Electroencephalography; Female; Hallucinations; Humans; Hypertension; Imipramine; Male; Methylphenidate; Middle Aged; Narcolepsy; Sleep, REM | 1974 |
Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport.
Topics: Amphetamine; Antidepressive Agents; Appetite Depressants; Chromatography, Thin Layer; Diethylpropion; Ephedrine; Humans; Hydrazines; Mephentermine; Methylphenidate; Monoamine Oxidase Inhibitors; Nicotine; Nikethamide; Pargyline; Phenmetrazine; Spectrophotometry; Sports Medicine; Tranylcypromine | 1967 |
[The chemical detection of doping among athletes].
Topics: Aminobutyrates; Amphetamine; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Ephedrine; Forensic Medicine; Humans; Methylphenidate; Sports Medicine; Substance-Related Disorders; Toxicology; Urine | 1966 |
Mass spectra of derivatives of phenylalkylamines.
Topics: Amphetamine; Chlorphentermine; Dopamine; Ephedrine; Epinephrine; Histamine; Isoproterenol; Methamphetamine; Methylphenidate; Norepinephrine; Phenethylamines; Phentermine; Phenylephrine; Phenylpropanolamine; Spectrum Analysis; Tryptamines; Tyramine | 1968 |
Behavioral facilitation: the interaction of imipramine and desipra- mine with amphetamine, alpha-pipradrol, methylphenidate, and thozalinone.
Topics: Amphetamine; Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Desipramine; Drug Synergism; Imipramine; Male; Methylphenidate; Oxazoles; Piperidines; Rats; Stimulation, Chemical | 1968 |
[Psychopharmacologic agents and the sense of smell].
Topics: Amphetamine; Antidepressive Agents; Bromine; Caffeine; Central Nervous System Stimulants; Chlordiazepoxide; Humans; Imipramine; Meclofenoxate; Meprobamate; Methylphenidate; Phenothiazines; Smell; Thioridazine; Tranquilizing Agents | 1968 |
[Psychopharmacological agents and taste].
Topics: Amphetamine; Antidepressive Agents; Bromine; Caffeine; Central Nervous System Stimulants; Chlordiazepoxide; Humans; Meclofenoxate; Meprobamate; Methylphenidate; Monoamine Oxidase Inhibitors; Nialamide; Phenothiazines; Taste; Tranquilizing Agents | 1968 |
[Contribution to the high-tension-electrophoresis of some phenylethyl amine-derivatives].
Topics: Amphetamine; Appetite Depressants; Chlorphentermine; Dopamine; Electrophoresis; Ephedrine; Epinephrine; Ethanolamines; Isoproterenol; Metaproterenol; Methamphetamine; Methods; Methylphenidate; Naphazoline; Octopamine; Phenethylamines; Phenmetrazine; Phentermine; Phenylephrine; Prenylamine; Serotonin; Sympathomimetics; Synephrine; Tryptamines; Tyramine | 1968 |
Stereotyped and non-stereotyped behaviour in rats induced by various stimulant drugs.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Caffeine; Central Nervous System; Cocaine; Lysergic Acid Diethylamide; Male; Methamphetamine; Methylphenidate; Nikethamide; Pemoline; Phenmetrazine; Piperidines; Rats | 1969 |
Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of alpha-methyltyrosine.
Topics: Amphetamine; Animals; Brain Chemistry; Diet; Dopamine; Drug Tolerance; Ephedrine; Male; Methylphenidate; Methyltyrosines; Mice; Motor Activity; Norepinephrine; Piperidines | 1969 |
The effects of psychotropic drugs on the double alley frustration effect.
Topics: Amobarbital; Amphetamine; Analysis of Variance; Animals; Antidepressive Agents; Central Nervous System; Central Nervous System Stimulants; Chlorpromazine; Conditioning, Psychological; Frustration; Iproniazid; Male; Methylphenidate; Pargyline; Rats; Reinforcement, Psychology; Reserpine; Tetrabenazine | 1969 |
[Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
Topics: Amphetamine; Analgesics; Animals; Avoidance Learning; Behavior, Animal; Blood Pressure; Body Temperature; Brain Chemistry; Caffeine; Cats; Central Nervous System; Chlordiazepoxide; Chlorpromazine; Drug Synergism; Ethanol; Haplorhini; Indoleacetic Acids; Male; Meprobamate; Methylphenidate; Mice; Morphine; Motor Activity; Pentobarbital; Piperidines; Rats; Reserpine; Respiration; Salivation; Seizures; Serotonin; Triazines | 1970 |
Release of norepinephrine and normetanephrine from cat brain by central nervous system stimulants.
Topics: Amphetamine; Animals; Brain; Caffeine; Cats; Chlorine; Cocaine; Dextroamphetamine; Ephedrine; Methylphenidate; Norepinephrine; Normetanephrine; Piperidines; Tritium | 1970 |
Hyperkineticism in children.
Topics: Amphetamine; Anticonvulsants; Child; Child Behavior Disorders; Humans; Hyperkinesis; Methylphenidate; Tranquilizing Agents | 1970 |
The effect of a number of drugs with different pharmacological properties upon reserpine induced hypothermia in mice.
Topics: Amphetamine; Animals; Antidepressive Agents; Body Temperature; Histamine H1 Antagonists; Hypnotics and Sedatives; Hypothermia; Methods; Methyldopa; Methylphenidate; Mice; Monoamine Oxidase Inhibitors; Orphenadrine; Parasympatholytics; Reserpine; Tranquilizing Agents; Tripelennamine | 1971 |
A survey of selected drugs on behavioral performance in ethanol-treated rats.
Topics: Amphetamine; Animals; Caffeine; Conditioning, Operant; Cyproheptadine; Drug Antagonism; Ethanol; Histamine H1 Antagonists; Imipramine; Male; Methylphenidate; Methyltyrosines; Pentylenetetrazole; Piperidines; Pyridines; Rats | 1971 |
The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey.
Topics: Amphetamine; Animals; Behavior, Animal; Chlorpromazine; Cocaine; Drug Antagonism; Humans; Macaca; Methylphenidate; Phenmetrazine; Piperidines; Self Stimulation; Stimulation, Chemical; Substance-Related Disorders | 1972 |
Proceedings: Effect of intravenous d-amphetamine, 1-amphetamine and methylphenidate in schizophrenics.
Topics: Amphetamine; Behavior; Dextroamphetamine; Hemodynamics; Humans; Methylphenidate; Psychiatric Status Rating Scales; Schizophrenia; Stimulation, Chemical | 1974 |
Conformationally constrained analogs of mescaline.
Topics: Amphetamine; Animals; Behavior, Animal; Exploratory Behavior; Male; Mescaline; Methods; Methylphenidate; Mice; Molecular Conformation; Morpholines; Motor Activity; Piperidines | 1974 |
A two factor theory of schizophrenia.
Topics: Acetylcholine; Amphetamine; Animals; Bipolar Disorder; Brain; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Humans; Methyl Ethers; Methylphenidate; Physostigmine; Schizophrenia; Stereoisomerism; Stereotyped Behavior | 1974 |
Sympathomimetic amines and gastric secretion in rats.
Topics: Amphetamine; Animals; Aporphines; Depression, Chemical; Gastric Fistula; Gastric Juice; Gastric Mucosa; Hydrogen-Ion Concentration; Ligation; Male; Methods; Methylphenidate; Methyltyrosines; Pylorus; Rats; Secretory Rate; Stimulation, Chemical | 1974 |
Amphetamines, valuable adjunct in treatment of Parkinsonism.
Topics: Aged; Amphetamine; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Methylphenidate; Parkinson Disease | 1973 |
Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei.
Topics: Amphetamine; Animals; Apomorphine; Atropine; Behavior; Caudate Nucleus; Cyproheptadine; Dextroamphetamine; Dibenzothiepins; Dioxoles; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Humans; Locomotion; Male; Mesencephalon; Methylphenidate; Piperazines; Putamen; Pyrimidines; Rats; Rats, Inbred Strains; Stereotaxic Techniques; Stereotyped Behavior; Stimulation, Chemical; Substantia Nigra; Sulfides; Time Factors | 1974 |
Self-inflicted strokes.
Topics: Amphetamine; Animals; Cerebral Angiography; Cerebrovascular Disorders; Fundus Oculi; Haplorhini; Humans; Injections, Intravenous; Methamphetamine; Methylphenidate; Narcotics; Rabbits; Substance-Related Disorders | 1972 |
Vascular complications of drug abuse.
Topics: Adult; Amphetamine; Amputation, Surgical; Aneurysm; Angiography; Arm; Arteries; Barbiturates; Blood Vessels; Candidiasis; Codeine; Endocarditis, Bacterial; Female; Heparin; Heroin; Humans; Injections, Intra-Arterial; Ischemia; Leg; Male; Methylphenidate; Substance-Related Disorders; Vascular Diseases; Vasodilator Agents; Veins | 1972 |
Antagonism of methylphenidate-induced stereotyped gnawing in mice.
Topics: Amphetamine; Animals; Behavior, Animal; Chlorpromazine; Humans; Male; Methylphenidate; Methyltyrosines; Mice; Motor Activity; Reserpine; Stereotyped Behavior; Stimulation, Chemical; Thioridazine | 1972 |
[Significance of amphetamine-like drugs in the psychodynamics of drug abuse in juveniles].
Topics: Adult; Amphetamine; Female; Hallucinations; Humans; Male; Methylphenidate; Psychoses, Substance-Induced; Substance-Related Disorders; Theophylline | 1973 |
Saturable transport of amphetamine across the blood-brain barrier.
Topics: Amphetamine; Animals; Arginine; Binding, Competitive; Biological Transport; Blood-Brain Barrier; Carbon Isotopes; Dextroamphetamine; Diffusion; Dopamine; Male; Methylphenidate; Phenethylamines; Phenylalanine; Phenylephrine; Rats; Tritium | 1973 |
The hyperactive child syndrome.
Topics: Age Factors; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child Behavior Disorders; Child, Preschool; Female; Humans; Hyperkinesis; Male; Methylphenidate; Motor Activity; Neurologic Manifestations; Psychological Tests; Sex Factors; Syndrome | 1973 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine | 1973 |
Patterns, range and effects of misused psychotropic substances in Europe.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Analgesics; Cannabis; Drug and Narcotic Control; Europe; Female; Heroin Dependence; Humans; Hypnotics and Sedatives; Lysergic Acid Diethylamide; Methylphenidate; Middle Aged; Phenmetrazine; Substance-Related Disorders; Tranquilizing Agents | 1973 |
Comparison of pemoline, amphetamine and methylphenidate effects upon the conditioned alimentary motor reflexes in cats.
Topics: Amphetamine; Animals; Cats; Conditioning, Classical; Methylphenidate; Pemoline | 1973 |
The hyperactive child.
Topics: Age Factors; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Hyperkinesis; Male; Methylphenidate; Psychological Tests; Social Adjustment | 1973 |
[The minimal brain dysfunction syndrome].
Topics: Affective Symptoms; Amphetamine; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Humans; Hyperkinesis; Methylphenidate; Prognosis; Tranquilizing Agents | 1973 |
Effect of nicotine on the swimming endurance of rats.
Topics: Amphetamine; Animals; Chlordiazepoxide; Dextroamphetamine; Diazepam; Injections, Intramuscular; Injections, Subcutaneous; Male; Methylphenidate; Nicotine; Rats; Swimming; Time Factors | 1973 |
Narcolepsy.
Topics: Accidents, Traffic; Adult; Amphetamine; Automobile Driving; Cataplexy; Female; Hallucinations; Humans; Male; Methylphenidate; Narcolepsy; Paralysis; Prognosis; Sleep Stages | 1974 |
Pharmacotherapeutics. Review and commentary.
Topics: Acetaminophen; Acetanilides; Amphetamine; Ampicillin; Analgesics; Anti-Bacterial Agents; Aspirin; Child; Child Behavior Disorders; Child, Preschool; Chloramphenicol; Costs and Cost Analysis; Drug Therapy; Erythromycin; Humans; Methylphenidate; Pediatrics; Penicillins; Tetracycline | 1974 |
Minimal brain dysfunctions in children.
Topics: Amphetamine; Attention; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Communication; Dyslexia; Emotions; Form Perception; Handwriting; Humans; Hyperkinesis; Imipramine; Intelligence Tests; Language Development; Learning Disabilities; Male; Methylphenidate; Motor Skills; Orientation; Pemoline; Psychomotor Disorders; Thioridazine | 1974 |
Pharmacology of neuroleptics upon repeated administration.
Topics: Amphetamine; Animals; Apomorphine; Avoidance Learning; Catalepsy; Cross Reactions; Dose-Response Relationship, Drug; Drug Tolerance; Ethanol; Fluphenazine; Germ-Free Life; Haloperidol; Humans; Male; Methylphenidate; Mice; Mice, Inbred Strains; Pimozide; Piperazines; Stereotyped Behavior; Thioxanthenes; Time Factors; Tranquilizing Agents | 1974 |
Lead-induced behavioral dysfunction: an animal model of hyperactivity.
Topics: Amphetamine; Animals; Chloral Hydrate; Dextroamphetamine; Disease Models, Animal; Female; Humans; Hyperkinesis; Lead Poisoning; Methylphenidate; Mice; Phenobarbital; Pregnancy; Time Factors | 1974 |
Hyperactivity: a lead-induced behavior disorder.
Topics: Amphetamine; Animals; Animals, Newborn; Chloral Hydrate; Diet; Dose-Response Relationship, Drug; Female; Humans; Hyperkinesis; Impulsive Behavior; Lead; Male; Methylphenidate; Mice; Mice, Inbred Strains; Milk; Motor Activity; Phenobarbital; Pregnancy; Time Factors; Water | 1974 |
[Psychostimulant treatment of "hyperkinetic" children].
Topics: Amphetamine; Child; Humans; Hyperkinesis; Methylphenidate | 1972 |
The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
Topics: Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Benzyl Compounds; Cats; Central Nervous System; Cocaine; Dextroamphetamine; Dihydroxyphenylalanine; Drug Antagonism; Hydrazines; Methyldopa; Methylphenidate; Methyltyrosines; Pemoline; Reserpine; Serine; Stimulation, Chemical | 1972 |
A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and
Topics: Amphetamine; Animals; Aorta; Benzene Derivatives; Brain; Cerebral Cortex; Corpus Striatum; Depression, Chemical; Dopamine; Hypothalamus; Male; Methylphenidate; Norepinephrine; Piperidines; Rats; Receptors, Drug; Stereoisomerism; Structure-Activity Relationship; Sympathetic Nervous System; Synaptosomes; Tritium | 1972 |
Dissociation of learning on stimulant-drug therapy.
Topics: Amphetamine; Animals; Antidepressive Agents; Child; Dextroamphetamine; Humans; Hyperkinesis; Learning; Learning Disabilities; Methylphenidate; Rats | 1972 |
Hyperactivity in children: types, diagosis, drug therapy, approaches to management.
Topics: Amphetamine; Anxiety; Attention; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chronic; Child; Chlordiazepoxide; Chlorpromazine; Dextroamphetamine; Diazepam; Environment; Family; Female; Humans; Hyperkinesis; Methylphenidate; Motor Skills; Phenytoin; Thioridazine | 1972 |
The use of amphetamines.
Topics: Amphetamine; Drug and Narcotic Control; Legislation, Drug; Methylphenidate; South Africa | 1972 |
Mood-altering drugs.
Topics: Amphetamine; Child; Child Behavior; Female; Humans; Hyperkinesis; Male; Methylphenidate; School Health Services; Sex Factors | 1971 |
Amphetamines in hyperkinetic children.
Topics: Amphetamine; Child; Humans; Hyperkinesis; Methylphenidate; Norepinephrine | 1971 |
Fluorometric determination of amphetamines with 3-carboxy-7-hydroxycoumarin.
Topics: Amphetamine; Benzphetamine; Chlorphentermine; Coumarins; Dextroamphetamine; Fluorometry; Methamphetamine; Methods; Methylphenidate; Morpholines; Phenmetrazine | 1971 |
Review of stimulant drugs in learning and behavior disorders.
Topics: Aggression; Amphetamine; Child; Child Behavior Disorders; Dextroamphetamine; Humans; Hyperkinesis; Learning Disabilities; Methylphenidate | 1971 |
Abuse of anorexics with special reference to newer substances.
Topics: Adolescent; Adult; Amines; Amphetamine; Appetite Depressants; Female; Humans; Methamphetamine; Methylphenidate; Middle Aged; Motivation; Obesity; Oxazoles; Propiophenones; Substance-Related Disorders | 1971 |
Morphine-withdrawal aggression: sensitization by amphetamines.
Topics: Aggression; Amphetamine; Animals; Dextroamphetamine; Humans; Hydroxylamines; Male; Methylphenidate; Morphine; Morphine Dependence; Rats; Substance Withdrawal Syndrome; Time Factors | 1971 |
Effect of some amphetamine analogues on -methyl-p-tyrosine-induced catalepsy in rats.
Topics: Amphetamine; Animals; Benzene Derivatives; Catalepsy; Drug Synergism; Ephedrine; Female; Humans; Methylphenidate; Methyltyrosines; Phenmetrazine; Rats | 1971 |
A comparison of the effects of cocaine and synthetic central stimulants.
Topics: Amphetamine; Central Nervous System; Cocaine; Dextroamphetamine; Humans; Methylphenidate; Phenmetrazine | 1970 |
Drug effects on canary steriotypies.
Topics: Amphetamine; Animals; Arousal; Behavior, Animal; Canaries; Carisoprodol; Chlordiazepoxide; Chlorpromazine; Drinking Behavior; Feeding Behavior; Grooming; Methylphenidate; Motor Activity; Placebos | 1969 |
Derivatives of sympathomimetic amines for gas chromatography with electron capture detection and mass spectrometry.
Topics: Amines; Amphetamine; Chlorphentermine; Chromatography, Gas; Diethylpropion; Electrons; Methamphetamine; Methylphenidate; Phenmetrazine; Spectrum Analysis; Trichloroacetic Acid | 1969 |
Coping on amphetamines.
Topics: Amphetamine; Antidepressive Agents; Brain Damage, Chronic; Child; Child Behavior Disorders; Deanol; Humans; Methylphenidate; Pentylenetetrazole | 1970 |
Speed in Sweden.
Topics: Amphetamine; Humans; Methylphenidate; Phenmetrazine; Substance-Related Disorders; Sweden | 1970 |
[Central-stimulating amines--international control].
Topics: Amphetamine; Dextroamphetamine; Drug and Narcotic Control; International Agencies; International Cooperation; Methamphetamine; Methylphenidate; Norway; Phenmetrazine; World Health Organization | 1970 |
[Trends and perspectives of psychopharmacology].
Topics: Amphetamine; Antidepressive Agents; Caffeine; Hallucinogens; Humans; Hypnotics and Sedatives; Mental Disorders; Methylphenidate; Psychopharmacology; Tranquilizing Agents | 1970 |
An analysis of methylphenidate induced gnawing in guinea pigs.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Drug Antagonism; Female; Guinea Pigs; Haloperidol; Male; Methyldopa; Methylphenidate; Methyltyrosines; Tranylcypromine | 1970 |
Metastatic endophthalmitis associated with injection of addictive drugs.
Topics: Adult; Amphetamine; Aspergillosis; Cannabis; Eye Diseases; Heroin; Humans; Inflammation; Injections, Intravenous; Lysergic Acid Diethylamide; Male; Methylphenidate; Morphine Dependence; Mycoses; Substance-Related Disorders | 1971 |
The effect of various antidepressant drugs upon the tetrabenazine-suppressed conditioned avoidance response in rats.
Topics: Amphetamine; Animals; Antidepressive Agents; Avoidance Learning; Desipramine; Escape Reaction; Imipramine; Iproniazid; Male; Methylphenidate; Pargyline; Rats; Tetrabenazine | 1971 |
Learning disorders, hyperkinesis, and the use of drugs in children.
Topics: Amphetamine; Child; Humans; Hyperkinesis; Learning Disabilities; Methylphenidate; Psychological Tests; Substance-Related Disorders | 1971 |
[Differential action of amphetamine on spontaneous and conditioned locomotor behavior in rats].
Topics: Amphetamine; Animals; Avoidance Learning; Conditioning, Psychological; Methylphenidate; Motor Activity; Rats | 1967 |
Drugs for depression.
Topics: Amphetamine; Antidepressive Agents; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Obesity; Phenmetrazine; Psychoses, Substance-Induced; Substance-Related Disorders | 1968 |
[Pharmacologic changes in feeding behavior: food intake and rumination in sheep].
Topics: Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Cerebral Cortex; Chlorpromazine; Digestion; Digitalis Glycosides; Eating; Imipramine; Iproniazid; Lanatosides; Mescaline; Methylphenidate; Morphine; Ouabain; Pentobarbital; Psychopharmacology; Reticulum; Rumen; Sheep; Theophylline | 1968 |
The hypnotic properties of 8-ethylthio-6-thiotheophylline sodium.
Topics: Amphetamine; Animals; Caffeine; Chloral Hydrate; Chlorpromazine; Dogs; Drug Synergism; Hexobarbital; Hypnotics and Sedatives; Male; Meprobamate; Methylphenidate; Mice; Morphine; Nalorphine; Nikethamide; Pentobarbital; Pentylenetetrazole; Phenobarbital; Rabbits; Rats; Reserpine; Sleep; Theophylline; Thiopental | 1968 |
The effects of amphetamine, caffeine and methylphenidate on the locomotor activity of rats in an unfamiliar environment.
Topics: Amphetamine; Animals; Caffeine; Learning; Male; Methylphenidate; Motor Activity; Rats; Stimulation, Chemical | 1968 |
[Contribution to the separation of psychostimulant amines by gas phase chromatography].
Topics: Amphetamine; Chromatography, Gas; Ephedrine; Humans; Methamphetamine; Methods; Methylphenidate; Phenmetrazine | 1968 |
Antidepressive drugs.
Topics: Adolescent; Adult; Aged; Amitriptyline; Amphetamine; Antidepressive Agents; Classification; Depression; Humans; Hydrazines; Imipramine; Methylphenidate; Middle Aged; Tranylcypromine | 1965 |
[Demonstration of centrally stimulating substances in pure form and after passage through the body by thin-layer chromatography].
Topics: Amphetamine; Antidepressive Agents; Chromatography, Thin Layer; Diethylpropion; Humans; In Vitro Techniques; Methamphetamine; Methylphenidate; Phenmetrazine; Sympathomimetics; Urine | 1965 |
Gas chromatographic separation and identification of some sympathomimetic amines in use in anorexigenic drugs.
Topics: Alcohols; Amphetamine; Appetite Depressants; Chlorphentermine; Chromatography, Gas; Diethylpropion; Methamphetamine; Methylphenidate; Morpholines; Phenmetrazine; Phentermine; Sympathomimetics | 1966 |
Four cases of progressive drug abuse.
Topics: Adult; Alcohols; Amphetamine; Barbiturates; Cannabis; Cocaine; Humans; Lysergic Acid Diethylamide; Male; Methylphenidate; Morphine; Opium; Substance-Related Disorders | 1967 |
The selective inhibitory effect of EGTA on the circling behaviour produced by amphetamine but not methylphenidate in mice lesioned with 6-hydroxydopamine.
Topics: Amphetamine; Animals; Corpus Striatum; Dopamine; Egtazic Acid; Ethylene Glycols; Hydroxydopamines; Male; Methylphenidate; Mice; Motor Activity; Time Factors | 1980 |
Differential effects of (+)-amphetamine, methylphenidate, and amfonelic aid on catecholamine synthesis in selected regions of the rat brain.
Topics: Amphetamine; Animals; Brain; Catecholamines; Dihydroxyphenylalanine; Male; Methylphenidate; Nalidixic Acid; Naphthyridines; Rats; Rats, Inbred Strains | 1981 |
The differential effects of amphetamine and methylphenidate on the biosynthesis of [3H]dopa from [3H]tyrosine in mouse striata in vivo.
Topics: Amphetamine; Animals; Benserazide; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Male; Methylphenidate; Mice; Synaptosomes; Tyrosine | 1982 |
Arousal, temporal and spatial uncertainty and drug effects.
Topics: Adult; Alcohol Drinking; Amphetamine; Antipsychotic Agents; Arousal; Attention; Attention Deficit Disorder with Hyperactivity; Child; Chlorpromazine; Discrimination Learning; Humans; Mental Recall; Methylphenidate; Motor Activity; Orientation; Psychotropic Drugs; Reaction Time; Space Perception | 1983 |
Play soliciting in juvenile male rats: effects of caffeine, amphetamine and methylphenidate.
Topics: Amphetamine; Animals; Caffeine; Central Nervous System Stimulants; Drug Interactions; Male; Methylphenidate; Play and Playthings; Rats; Scopolamine; Social Behavior; Time Factors | 1983 |
Cholinergic modulation of stimulant-induced behavior.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Drug Interactions; Humans; Male; Methylphenidate; Motor Activity; Neurons; Parasympathetic Nervous System; Physostigmine; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1984 |
Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Dronabinol; Female; Humans; Male; Methylphenidate; Motor Activity; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior | 1984 |
[Characteristics of reverse tolerance to ambulation-increasing effect of methylphenidate after repeated administration in mice].
Topics: Amphetamine; Animals; Conditioning, Psychological; Drug Tolerance; Male; Methamphetamine; Methylphenidate; Mice; Mice, Inbred Strains; Motor Activity | 1983 |
gamma-Butyrolactone effects on behavior induced by dopamine agonists.
Topics: 4-Butyrolactone; Amphetamine; Animals; Apomorphine; Bicuculline; Furans; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Male; Methylphenidate; Rats; Receptors, Dopamine; Stereotyped Behavior | 1983 |
Self-stimulation and amphetamine: tolerance to d and l isomers and cross tolerance to cocaine and methylphenidate.
Topics: Amphetamine; Animals; Cocaine; Dextroamphetamine; Drug Tolerance; Male; Methylphenidate; Rats; Self Stimulation | 1981 |
Abused drugs, street drugs, and drug misuse.
Topics: Amphetamine; Drug and Narcotic Control; Drug Prescriptions; Illicit Drugs; Ketamine; Methylphenidate; Pentazocine; Pharmaceutical Preparations; United States; Veterinary Medicine | 1982 |
The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior.
Topics: Amphetamine; Amphetamines; Animals; Apomorphine; Brain; Cocaine; Dextroamphetamine; Dopamine; Feeding Behavior; Haloperidol; Levodopa; Methylphenidate; Rats; Spiperone | 1980 |
Synthesis and pharmacology of hydroxylated metabolites of methylphenidate.
Topics: Amphetamine; Animals; Hydroxylation; Male; Methylphenidate; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism | 1981 |
A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices.
Topics: Amphetamine; Animals; Caudate Nucleus; Dopamine; In Vitro Techniques; Male; Methylphenidate; Rats; Reserpine; Tyramine | 1980 |
Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Topics: Amphetamine; Animals; Binding Sites; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Ethylmaleimide; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Neurons; Nomifensine; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley | 1994 |
Locomotor effects of nitrous oxide in mice: requirement of newly-synthesized and main intraneuronal storage pools of dopamine.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Dopamine; Drug Interactions; Male; Methylphenidate; Methyltyrosines; Mice; Motor Activity; Neurons; Nitrous Oxide; Reserpine; Tyrosine 3-Monooxygenase | 1993 |
Dyskinesias possibly induced by norpseudoephedrine.
Topics: Adult; Amphetamine; Appetite Depressants; Brain; Female; Humans; Magnetic Resonance Imaging; Methylphenidate; Middle Aged; Molecular Structure; Movement Disorders; Pemoline; Phenylpropanolamine; Structure-Activity Relationship; Torticollis | 1994 |
A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate.
Topics: Amphetamine; Animals; Dopamine; Dose-Response Relationship, Drug; Male; Methylphenidate; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 1993 |
Decreased incidence of spontaneous mammary gland neoplasms in female F344 rats treated with amphetamine, methylphenidate, or codeine.
Topics: Amphetamine; Analgesics, Opioid; Animals; Anticarcinogenic Agents; Body Weight; Carcinogenicity Tests; Central Nervous System Stimulants; Codeine; Female; Male; Mammary Neoplasms, Experimental; Methylphenidate; Mice; Mice, Inbred Strains; Rats; Rats, Inbred F344 | 1996 |
Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Brain; Cats; Central Nervous System Stimulants; Double-Blind Method; Genes, fos; Immunohistochemistry; Male; Methylphenidate; Modafinil; Neurons; Organ Specificity; Proto-Oncogene Proteins c-fos; Wakefulness | 1996 |
NNC-19-1228 and NNC 22-0031, novel neuroleptics with a "mesolimbic-selective" behavioral profile.
Topics: Amphetamine; Animals; Antipsychotic Agents; Avoidance Learning; Benzothiazoles; Benzoxazoles; Carbamates; Catalepsy; Discrimination, Psychological; Dose-Response Relationship, Drug; Male; Methylphenidate; Mice; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine; Stereotyped Behavior | 1997 |
Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine.
Topics: Amphetamine; Animals; Caudate Nucleus; Dopamine; Dopamine Agents; Extracellular Space; Hippocampus; Methylphenidate; Microdialysis; Norepinephrine; Putamen; Rats; Serotonin | 1997 |
Voltammetric approaches to kinetics and mechanism of the norepinephrine transporter.
Topics: Amphetamine; Carrier Proteins; Cell Line; Dopamine; Electrophysiology; Humans; Kinetics; Methylphenidate; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Phenethylamines; Psychotropic Drugs; Symporters | 1998 |
Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists?
Topics: Algorithms; Amphetamine; Animals; Binding, Competitive; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Electrodes; In Vitro Techniques; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Neostriatum; Nerve Tissue Proteins; Phenethylamines; Rats; Rats, Sprague-Dawley | 1999 |
Indirect dopamine agonists augment the locomotor activating effects of the kappa-opioid receptor agonist U-50,488 in preweanling rats.
Topics: Age Factors; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Benzofurans; Cocaine; Dopamine Agonists; Drug Interactions; Female; Locomotion; Male; Methylphenidate; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Stereotyped Behavior | 1999 |
Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.
Topics: Amphetamine; Animals; Behavior, Animal; Brain Chemistry; Caudate Nucleus; Central Nervous System Stimulants; Cocaine; Dopamine Uptake Inhibitors; Male; Methylphenidate; Microdialysis; Motor Activity; Nucleus Accumbens; Putamen; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Time Factors | 1999 |
[3H]beta-CIT: a radioligand for dopamine transporters in rat brain tissue.
Topics: Amphetamine; Animals; Autoradiography; Binding, Competitive; Brain; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Tritium | 1999 |
Similar effects of amphetamine and methylphenidate on the performance of complex operant tasks in rats.
Topics: Amphetamine; Animals; Attention; Brain; Catecholamines; Central Nervous System Stimulants; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mental Recall; Methylphenidate; Motivation; Orientation; Rats; Rats, Sprague-Dawley; Reaction Time; Time Perception | 2000 |
Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine.
Topics: Amphetamine; Analysis of Variance; Animals; Dopamine; Dopamine Agents; Drug Interactions; Hippocampus; Male; Methylphenidate; Motor Activity; Norepinephrine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley | 2001 |
[Drug treatment of school children with attention deficit and hyperactivity disorder].
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Norway; School Health Services; Surveys and Questionnaires | 2001 |
Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Body Height; Body Weight; Central Nervous System Stimulants; Child; Child, Preschool; Growth Disorders; Humans; Male; Methylphenidate; Norway; Time Factors | 2002 |
Dopamine transporter-dependent induction of C-Fos in HEK cells.
Topics: Amphetamine; Cell Line; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Synergism; Humans; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Proto-Oncogene Proteins c-fos; RNA, Messenger | 2002 |
[Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
Topics: Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Humans; Methylphenidate; Practice Guidelines as Topic; Sweden | 2002 |
Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
Topics: Amphetamine; Animals; Blotting, Western; Cell Count; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Female; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Mice; Mice, Knockout; Mutation; Nerve Tissue Proteins; Neural Pathways; Proto-Oncogene Proteins c-fos; Time Factors | 2003 |
Effects of central excitant and depressant drugs on locomotor activity in the monkey.
Topics: Amphetamine; Amphetamines; Animals; Central Nervous System; Chlorpromazine; Haplorhini; Meprobamate; Methylphenidate; Motor Activity; Reserpine | 1957 |
Some effects of methyl-phenidate (ritalin) and amphetamine on normal and leucotomized monkeys.
Topics: Amphetamine; Amphetamines; Animals; Haplorhini; Methylphenidate; Psychosurgery | 1957 |
[Behavior of experimental catatonia induced by bulbocapnine in rats under the action of various drugs. III. Action of various so-called psychomimetic substances].
Topics: Alkaloids; Amphetamine; Amphetamines; Animals; Aporphines; Catatonia; Methylphenidate; Rats | 1957 |
Newer stimulant drugs.
Topics: Amphetamine; Amphetamines; Brain; Central Nervous System; Central Nervous System Stimulants; Humans; Methylphenidate | 1958 |
[Effect of phenothiazine derivatives on increased motility of the mouse].
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Chlorpromazine; Methylphenidate; Mice; Movement Disorders; Phenothiazines | 1958 |
[Effects of iproniazid on increased spontaneous motility due to central stimulants].
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Iproniazid; Methylphenidate; Movement Disorders; Niacin; Nicotinic Acids; Piperidines | 1958 |
Effect of centrally acting drugs upon muscular exercise in rats.
Topics: Alkaloids; Amphetamine; Amphetamines; Animals; Central Nervous System Agents; Exercise; Methylphenidate; Muscles; Rats; Tranquilizing Agents | 1959 |
The place of stimulant drugs in the therapy of stress disorder.
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Humans; Methylphenidate; Stress, Physiological | 1959 |
A rapid method for assessing drug inhibition of feeding behavior.
Topics: Amphetamine; Amphetamines; Appetite; Dextroamphetamine; Diethylpropion; Feeding Behavior; Humans; Methamphetamine; Methylphenidate; Oxazoles; Phenmetrazine | 1963 |
Phenylisopropylamine derivatives, structure and action.
Topics: Amphetamine; Chlorpromazine; Dibucaine; Diethylpropion; Dihydroxyphenylalanine; Dopamine; Ephedrine; Epinephrine; Hydrazines; Imipramine; Iproniazid; Mephentermine; Methamphetamine; Methylphenidate; Movement; Nialamide; Phenelzine; Phenethylamines; Phenmetrazine; Phenylhydrazines; Piperidines; Reserpine; Tranylcypromine; Tryptophan; Tyramine | 1962 |
Drug and strain effects on performance and reversal of a head-position habit.
Topics: Amphetamine; Amphetamines; Chlorpromazine; Conditioning, Classical; Conditioning, Psychological; Extinction, Psychological; Habits; Humans; Meprobamate; Methylphenidate; Morphine; Pentobarbital; Reinforcement, Psychology | 1963 |
NARCOLEPSY. A DISCUSSION AND CASE PRESENTATION.
Topics: Amphetamine; Amphetamines; Cataplexy; Diagnosis, Differential; Genetics, Medical; Hallucinations; Humans; Hypothalamus; Methamphetamine; Methylphenidate; Narcolepsy; Paralysis; Sleep Wake Disorders | 1963 |
EFFECT OF STIMULANTS ON ISOLATED RATS.
Topics: Amphetamine; Amphetamines; Animals; Avoidance Learning; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Hydrazines; Methylphenidate; Noise; Pharmacology; Piperidines; Rats; Research; Tranylcypromine | 1963 |
[COMPARISONS OF POSTGANGLIONAL ENERVATION WITH THE ACTION OF CERTAIN SUBSTANCES ON THE NICTITATING MEMBRANE OF THE CAT].
Topics: Amphetamine; Amphetamines; Animals; Bretylium Compounds; Cats; Cocaine; Epinephrine; Guanethidine; Methylphenidate; Nictitating Membrane; Norepinephrine; Pharmacology; Phenethylamines; Research; Reserpine; Sympathectomy; Tyramine | 1963 |
[SOME CENTRAL EFFECTS OF SCHIZANDRA CHINENSIS EXTRACT].
Topics: Amphetamine; Amphetamines; Animals; Central Nervous System; Central Nervous System Stimulants; Methylphenidate; Mice; Nicotine; Research; Schisandra | 1963 |
NOREPINEPHRINE STORAGE AND ACUTE TOLERANCE.
Topics: Adrenalectomy; Amphetamine; Amphetamines; Animals; Blood Pressure; Blood Pressure Determination; Cocaine; Dogs; Drug Tolerance; Electrocardiography; Methamphetamine; Methylphenidate; Norepinephrine; Pharmacology; Research; Splenectomy | 1963 |
MODIFICATION BY IONISING RADIATION OF THE CENTRAL NERVOUS REACTIVITY TO STIMULATING DRUGS.
Topics: Amphetamine; Amphetamines; Caffeine; Central Nervous System; Electrocardiography; Electroencephalography; Methylphenidate; Mice; Pentylenetetrazole; Pharmacology; Rabbits; Radiation Injuries; Radiation Injuries, Experimental; Radiation, Ionizing; Rats; Research | 1963 |
A RELIABLE TRUCE WITH ENURESIS.
Topics: Adolescent; Amphetamine; Amphetamines; Atropa belladonna; Bromides; Child; Enuresis; Humans; Imipramine; Meprobamate; Methantheline; Methylphenidate; Piperidines; Quaternary Ammonium Compounds; Reserpine; Sympathomimetics | 1964 |
A CLINICAL APPRAISAL OF DRUGS USED FOR CARDIORESPIRATORY RESUSCITATION.
Topics: Amphetamine; Amphetamines; Barium; Bemegride; Bicarbonates; Calcium; Cyanides; Epinephrine; Humans; Isoproterenol; Lactates; Lidocaine; Lobeline; Methylphenidate; Nalorphine; Nicotine; Nikethamide; Norepinephrine; Pentylenetetrazole; Pharmacology; Picrotoxin; Potassium; Procaine; Resuscitation; Toxicology | 1964 |
[ACUTE POISONING WITH PSYCHOMIMETICS].
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Imipramine; Methylphenidate; Orphenadrine; Phenmetrazine; Toxicology | 1964 |
[MODIFICATIONS OF EXCITABILITY OF THE VASOMOTOR CENTERS BY SUBSTANCES INTERFERING PERIPHERALLY WITH THE EFFECTS OF THE SYMPATHETIC NERVOUS SYSTEM].
Topics: Amphetamine; Amphetamines; Blood Pressure; Bretylium Compounds; Cats; Cocaine; Dibenzylchlorethamine; Diencephalon; Ephedrine; Ergotamine; Guanethidine; Hydrazines; Iproniazid; Isoproterenol; Medulla Oblongata; Methylphenidate; Monoamine Oxidase Inhibitors; Pharmacology; Phenoxybenzamine; Research; Sensory Receptor Cells; Sympathetic Nervous System; Sympatholytics; Yohimbine | 1964 |
ACTIONS OF ASARONE ON BEHAVIOR, STRESS, AND HYPERPYREXIA, AND ITS INTERACTION WITH CENTRAL STIMULANTS.
Topics: Allylbenzene Derivatives; Amphetamine; Amphetamines; Animals; Anisoles; Behavior, Animal; Central Nervous System Stimulants; Fever; Haplorhini; Imipramine; Isoniazid; Lysergic Acid Diethylamide; Methylphenidate; Mice; Pharmacology; Rats; Research; Stress, Physiological; Tranquilizing Agents | 1964 |
BEHAVIOR DISORDERS OF CHILDREN WITH CEREBRAL DYSRHYTHMIAS; SUCCESSFUL TREATMENT OF SUBCONVULSIVE DYSRHYTHMIA WITH ANTICONVULSANTS.
Topics: Acetazolamide; Amphetamine; Amphetamines; Anticonvulsants; Child; Child Behavior Disorders; Conduct Disorder; Drug Therapy; Electroencephalography; Humans; Methylphenidate; Phenobarbital; Phenytoin; Seizures; Succinimides | 1964 |
EARLY RECOGNITION OF DEPRESSION.
Topics: Amitriptyline; Amphetamine; Amphetamines; Barbiturates; Benactyzine; Chlordiazepoxide; Deanol; Depression; Depressive Disorder; Diagnosis; Diazepam; Drug Therapy; Geriatrics; Humans; Imipramine; Meprobamate; Methylphenidate; Monoamine Oxidase Inhibitors; Phenmetrazine; Piperidines; Psychotherapy; Toxicology | 1964 |
INFLUENCE OF DOXAPRAM HYDROCHLORIDE ON RECOVERY FROM THIOPENTAL ANAESTHESIA.
Topics: Adolescent; Amphetamine; Amphetamines; Anesthesia; Anesthesia, Intravenous; Animals; Biomedical Research; Central Nervous System Diseases; Central Nervous System Stimulants; Dogs; Doxapram; Methylphenidate; Pharmacology; Surgical Procedures, Operative; Thiopental | 1965 |
DRUG-INDUCED DISSOCIATION BETWEEN EVOKED RETICULAR POTENTIALS AND THE EEG.
Topics: Amphetamine; Amphetamines; Animals; Antidepressive Agents; Atropine; Brain; Caffeine; Catechols; Central Nervous System Stimulants; Chlordiazepoxide; Chlorpromazine; Electroencephalography; Electrophysiology; Hallucinogens; Humans; Imipramine; Methamphetamine; Methylphenidate; Paraldehyde; Pentobarbital; Pentylenetetrazole; Phenoxybenzamine; Rabbits; Research; Reticular Formation; Scopolamine; Thioridazine; Tranquilizing Agents | 1965 |
ANTAGONISM OF THE BLOCKING ACTION OF BRETYLIUM AND GUANETHIDINE ON THE PRESSOR EFFECT OF PHYSOSTIGMINE IN THE RAT.
Topics: Amphetamine; Amphetamines; Blood Pressure; Bretylium Compounds; Cocaine; Dextroamphetamine; Guanethidine; Imipramine; Methylphenidate; Norepinephrine; Pharmacology; Physostigmine; Rats; Research; Reserpine; Sympatholytics; Vasoconstrictor Agents; Vasomotor System | 1965 |
[Disorders of behavior induced by amphetamine and phenidylate (ritalin) in the rat].
Topics: Amphetamine; Amphetamines; Animals; Methylphenidate; Rats | 1960 |
Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine.
Topics: Aging; Amphetamine; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Methylphenidate; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior | 2003 |
Effect of amphetamine, cocaine and depolarization by high potassium on extracellular dopamine in the nucleus accumbens shell of SHR rats. An in vivo microdyalisis study.
Topics: Amphetamine; Analysis of Variance; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Fluid; Male; Matched-Pair Analysis; Membrane Potentials; Methylphenidate; Microdialysis; Nucleus Accumbens; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2003 |
The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Topics: Amphetamine; Animals; Animals, Outbred Strains; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Corpus Striatum; Denervation; Disease Models, Animal; Male; Methylphenidate; Mice; Mice, Knockout; Motor Activity; Neural Pathways; Oxidopamine; Phenotype; Receptors, Dopamine D2; Receptors, Dopamine D4; Substantia Nigra; Sympatholytics | 2004 |
Methylphenidate restores ventral tegmental area dopamine neuron activity in prenatal ethanol-exposed rats by augmenting dopamine neurotransmission.
Topics: Amphetamine; Animals; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Interactions; Electrophysiology; Ethanol; Female; Methylphenidate; Neurons; Nomifensine; Piperazines; Prazosin; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area | 2004 |
Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate.
Topics: Amphetamine; Animals; Attention; Caffeine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Male; Methylphenidate; Nicotine; Rats; Reaction Time | 2004 |
Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Intellectual Disability; Irritable Mood; Methylphenidate; Motor Activity; Personality Assessment; Quality of Life; Social Behavior; Treatment Outcome | 2004 |
Treating adolescent girls and women with ADHD: gender-specific issues.
Topics: Adolescent; Adult; Age Factors; Amphetamine; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Comorbidity; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Estrogens; Female; Humans; Learning Disabilities; Male; Methylphenidate; Sex Distribution; Sex Factors; Substance-Related Disorders | 2005 |
Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.
Topics: Amphetamine; Animals; Dopamine; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Male; Methylphenidate; Motor Activity; Neurons; Rats; Rats, Inbred WKY; Rats, Wistar; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Ventral Tegmental Area | 2005 |
A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
Topics: Amino Acid Substitution; Amphetamine; Animals; Biological Transport; Blotting, Western; Cell Line; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Haplorhini; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Mice; Mice, Knockout; Mutagenesis; Mutation; Nerve Tissue Proteins; Phenylalanine; Protein Structure, Tertiary; Radioligand Assay; Transfection; Tritium | 2005 |
Age-specific behavioral responses to psychostimulants in mice.
Topics: Aging; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Male; Methylphenidate; Mice; Motor Activity; Stereotyped Behavior | 2005 |
Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Extracellular Fluid; Female; Male; Methylphenidate; Microdialysis; Papio; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Synapses | 2006 |
Visual function and ocular features in children and adolescents with attention deficit hyperactivity disorder, with and without treatment with stimulants.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Convergence, Ocular; Depth Perception; Eye; Female; Fluorescein Angiography; Humans; Male; Methylphenidate; Mydriatics; Ocular Physiological Phenomena; Refraction, Ocular; Strabismus; Vision Tests; Vision, Binocular; Visual Acuity; Visual Perception | 2007 |
The latest drugs on the FDA's radar.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Contraindications; Drug Approval; Humans; Methylphenidate; United States; United States Food and Drug Administration | 2006 |
[Medication for ADHD and the risk of cardiovascular mortality].
Topics: Amphetamine; Arrhythmias, Cardiac; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Central Nervous System Stimulants; Child; Death, Sudden, Cardiac; Female; Humans; Male; Methylphenidate; Risk Factors | 2006 |
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Carbon Isotopes; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Homovanillic Acid; Immunohistochemistry; Macaca fascicularis; Male; Manganese; Methylphenidate; Models, Neurological; Motor Skills; Positron-Emission Tomography; Raclopride; Radioligand Assay; Receptors, Dopamine; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Corpus Striatum; Methylphenidate; Mice; Mice, Knockout; Motor Activity; Phosphoproteins; Psychotropic Drugs; Serotonin; Serotonin Receptor Agonists; Signal Transduction | 2006 |
Fluctuation of the dopamine uptake inhibition potency of cocaine, but not amphetamine, at mammalian cells expressing the dopamine transporter.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Benztropine; Binding, Competitive; Brain; Brain Chemistry; Cell Line, Tumor; Chlorocebus aethiops; CHO Cells; Cocaine; Cocaine-Related Disorders; COS Cells; Cricetinae; Cricetulus; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Mazindol; Methylphenidate; Neurons; Radioligand Assay | 2007 |
Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Male; Methylphenidate; Motor Activity; Rats; Rats, Wistar; Risk; Substance-Related Disorders | 2007 |
Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2.
Topics: Amphetamine; Animals; Blotting, Western; Cell Membrane; Central Nervous System Stimulants; Cytoplasm; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Methylphenidate; Protein Transport; Rats; Rats, Sprague-Dawley; Synaptosomes; Vesicular Monoamine Transport Proteins | 2007 |
[Prescribing of stimulants for ADHD in Nordland County].
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Prescriptions; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Propylamines | 2007 |
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
Topics: Adenosine Triphosphate; Amphetamine; Animals; Atomoxetine Hydrochloride; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Biological Transport; Central Nervous System Stimulants; Cyclosporins; Dose-Response Relationship, Drug; Doxorubicin; Isomerism; LLC-PK1 Cells; Methylphenidate; Modafinil; Propylamines; Reproducibility of Results; Rhodamine 123; Swine; Transfection | 2008 |
Deficiency in inhibitory cortical interneurons associates with hyperactivity in fibroblast growth factor receptor 1 mutant mice.
Topics: Amphetamine; Animals; Behavior, Animal; Biogenic Monoamines; Cell Count; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; Dopamine Agents; Exploratory Behavior; Fibroblast Growth Factor 1; Glutamate Decarboxylase; Hyperkinesis; Locomotion; Male; Methylphenidate; Mice; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Neural Inhibition; Neurons; Signal Transduction | 2008 |
School-based administration of ADHD drugs decline, along with diversion, theft, and misuse.
Topics: Amphetamine; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Attitude of Health Personnel; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Child; Confidentiality; Delayed-Action Preparations; Drug Administration Schedule; Drug and Narcotic Control; Drug Utilization; Health Services Needs and Demand; Humans; Methylphenidate; Nursing Methodology Research; Nursing Staff; Patient Admission; Patient Selection; School Nursing; Surveys and Questionnaires; Theft; United States | 2007 |
Increasing use of stimulants warns of potential abuse.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Drug Prescriptions; Humans; Methylphenidate; Substance-Related Disorders; United States; World Health Organization | 2008 |
Impulsive choice and environmental enrichment: effects of d-amphetamine and methylphenidate.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Conditioning, Operant; Dopamine Agents; Environment; Impulsive Behavior; Injections, Subcutaneous; Male; Methylphenidate; Motor Activity; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reinforcement, Psychology; Reward; Substance-Related Disorders | 2008 |
Anomalous dopamine release associated with a human dopamine transporter coding variant.
Topics: Alanine; Amphetamine; Analysis of Variance; Biotinylation; Cell Line, Transformed; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Humans; Membrane Potentials; Methylphenidate; Mutation; Patch-Clamp Techniques; Protein Transport; Sodium; Transfection; Valine | 2008 |
Children's self-reports on perceived effects on taking stimulant medication for ADHD.
Topics: Achievement; Adolescent; Aggression; Amphetamine; Attention Deficit Disorder with Hyperactivity; Attitude to Health; Awareness; Central Nervous System Stimulants; Child; Female; Humans; Male; Methylphenidate; Motivation; Patient Satisfaction; Personality Assessment; Psychometrics; Social Behavior; Social Environment; Surveys and Questionnaires; Sweden | 2009 |
Acceleration tolerance at night with acute fatigue and stimulants.
Topics: Acceleration; Adaptation, Physiological; Adult; Aerospace Medicine; Amphetamine; Analysis of Variance; Benzhydryl Compounds; Central Nervous System Stimulants; Circadian Rhythm; Cognition; Fatigue; Humans; Male; Methylphenidate; Modafinil; Pemoline; Physical Endurance; Sleep Deprivation | 2008 |
Treating adult ADHD with stimulants.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Methylphenidate; Young Adult | 2008 |
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat.
Topics: Acetamides; Acetylcholine; Amphetamine; Animals; Behavior, Animal; Cognition; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Routes; Extracellular Fluid; Male; Memory Disorders; Methylphenidate; Microdialysis; Motor Activity; Pattern Recognition, Visual; Photic Stimulation; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D4; Reward | 2008 |
Stimulant dosing for children with ADHD: a medical claims analysis.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methylphenidate | 2009 |
Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Cocaine; Conditioning, Psychological; Dopamine Uptake Inhibitors; Exploratory Behavior; Genotype; Male; Methylphenidate; Mice; Mice, Knockout; Motor Activity; Random Allocation; Receptors, Dopamine D4 | 2010 |
Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Child, Preschool; Female; Heart; Heart Rate; Humans; Male; Methylphenidate; Proportional Hazards Models; Retrospective Studies; Young Adult | 2009 |
Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells.
Topics: Adenosine Triphosphate; Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Cell Line, Tumor; Cell Survival; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Methylphenidate; Monocytes; Neuroblastoma; Propylamines; U937 Cells | 2010 |
Critical role of the embryonic mid-hindbrain organizer in the behavioral response to amphetamine and methylphenidate.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Male; Methylphenidate; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Motor Activity; Neurons; Rhombencephalon; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2009 |
Nonmedical prescription stimulant use among a sample of college students: relationship with psychological variables.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Analysis of Variance; Female; Health Behavior; Health Surveys; Humans; Male; Methylphenidate; Prescription Drugs; Risk Factors; Self Medication; Students; Surveys and Questionnaires; Universities | 2009 |
Outcomes after accidental pediatric ingestions of (dextro)amphetamine and methylphenidate.
Topics: Accidents; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Infant; Male; Methylphenidate; Poisoning; Treatment Outcome | 2009 |
Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Drug Utilization; Female; Follow-Up Studies; Humans; Infant; Male; Methylphenidate; Patient Dropouts; Practice Patterns, Physicians'; Social Adjustment; Substance-Related Disorders; Sweden; Treatment Outcome | 2009 |
The effects of adolescent methylphenidate self-administration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation.
Topics: Age Factors; Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Early Growth Response Protein 1; Male; Methylphenidate; Motor Activity; Neurons; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reward; RNA, Messenger; Self Administration | 2010 |
Forebrain overexpression of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Casein Kinase Idelta; Dizocilpine Maleate; Down-Regulation; Excitatory Amino Acid Antagonists; Locomotion; Methylphenidate; Mice; Prosencephalon; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2010 |
Peripheral vasculopathy associated with psychostimulant treatment in children with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Male; Methylphenidate; Peripheral Vascular Diseases; Severity of Illness Index; Treatment Outcome | 2010 |
Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Atomoxetine Hydrochloride; Cell Line; Central Nervous System Stimulants; DNA Glycosylases; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Humans; Methylphenidate; Monocytes; Neuroblastoma; Propylamines; RNA, Messenger | 2010 |
GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice.
Topics: Adaptor Proteins, Signal Transducing; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Cell Cycle Proteins; Central Nervous System Stimulants; Child; Disease Models, Animal; Electroencephalography; Female; Genetic Predisposition to Disease; GTPase-Activating Proteins; Humans; Male; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Motor Activity; Neuropeptides; Phenotype; Polymorphism, Single Nucleotide; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Signal Transduction; Synaptic Transmission | 2011 |
Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder.
Topics: Achievement; Adolescent; Amphetamine; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Medicaid; Medication Adherence; Methylphenidate; Mood Disorders; Pemoline; Philadelphia; Psychotropic Drugs; United States; Urban Population | 2011 |
Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Choice Behavior; Disease Models, Animal; Dopamine Uptake Inhibitors; Fluphenazine; Impulsive Behavior; Methylphenidate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Reaction Time; Time Factors | 2011 |
Determination of amphetamine-type stimulants in oral fluid by solid-phase microextraction and gas chromatography-mass spectrometry.
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Diethylpropion; Gas Chromatography-Mass Spectrometry; Humans; Limit of Detection; Methamphetamine; Methylphenidate; Saliva; Solid Phase Microextraction | 2011 |
ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Female; Humans; Male; Medicaid; Medication Adherence; Methylphenidate; Prodrugs; Propylamines; Regression Analysis; Retrospective Studies; Texas; United States | 2011 |
(S)-(-)-N-(pentafluorobenzylcarbamoyl)prolyl chloride: a chiral derivatisation reagent designed for gas chromatography/negative ion chemical ionisation mass spectrometry of amino compounds.
Topics: Amphetamine; Caprylates; Carbamates; Central Nervous System Stimulants; Gas Chromatography-Mass Spectrometry; Indicators and Reagents; Ions; Methylphenidate; Proline; Stereoisomerism | 2012 |
Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice.
Topics: Amphetamine; Animals; Arrestins; Attention Deficit Disorder with Hyperactivity; beta-Arrestins; Brain Mapping; Central Nervous System Stimulants; Cerebral Cortex; Corpus Striatum; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Methylphenidate; Mice; Mice, Inbred C57BL; Oncogene Protein v-akt; Phosphorylation; Signal Transduction | 2012 |
The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Drosophila; Locomotion; Membrane Proteins; Methylphenidate; Mutation; Phosphorylation | 2013 |
The early history of the neuroscience of attention-deficit/hyperactivity disorder.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; History, 20th Century; Humans; Methylphenidate; Neurobiology; United States | 2012 |
A population-based study of stimulant drug treatment of ADHD and academic progress in children.
Topics: Achievement; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Educational Measurement; Female; Humans; Iceland; Language Arts; Male; Mathematics; Methylphenidate; Multivariate Analysis; Odds Ratio; Propylamines; Registries; Sex Factors; Treatment Outcome | 2012 |
Methylphenidate is distinguished from amphetamine in drug-of-abuse testing.
Topics: Amphetamine; Chromatography, Liquid; Humans; Methylphenidate; Substance Abuse Detection; Tandem Mass Spectrometry | 2012 |
Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Chromosome Aberrations; Data Interpretation, Statistical; Dopamine; Dopamine Plasma Membrane Transport Proteins; Executive Function; Growth; Macaca mulatta; Male; Methylphenidate; Motor Activity; Nervous System; Positron-Emission Tomography; Reaction Time; Receptors, Dopamine D2; Self Administration; Sister Chromatid Exchange | 2012 |
Long-term safety of stimulant use for ADHD: findings from nonhuman primates.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Male; Methylphenidate; Nervous System | 2012 |
Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.
Topics: Adolescent; Adult; Amphetamine; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Databases, Factual; Delayed-Action Preparations; Drug and Narcotic Control; Drug Prescriptions; Humans; Methylphenidate; Pharmacies; Poison Control Centers; Practice Patterns, Physicians'; Prescription Drug Misuse; United States | 2013 |
Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults.
Topics: Administration, Oral; Adult; Amphetamine; Amphetamines; Central Nervous System Stimulants; Cognition; Delayed-Action Preparations; Drug and Narcotic Control; Drug Costs; Humans; Infusions, Intravenous; Inhalation; Methylphenidate; Nootropic Agents; Personal Autonomy; Public Policy; Randomized Controlled Trials as Topic; Substance-Related Disorders; Taxes; United States | 2013 |
Enhancement policy and the value of information.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
Constraints on regulatory options for putatively cognitive enhancing drugs.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
There may be costs to failing to enhance, as well as to enhancing.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
Some first steps toward responsible use of cognitive-enhancing drugs by the healthy.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
How research on stakeholder perspectives can inform policy on cognitive enhancement.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
Moving beyond methylphenidate and amphetamine: the ethics of a better "smart drug".
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
The indirect psychological costs of cognitive enhancement.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
Regulating methylphenidate: enhancing cognition and social inequality.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
An argument for permitting amphetamines and instant-release methylphenidate.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
Tobacco: prohibition, coffee shops, or discouragement?
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
A liberal consequentialist approach to regulation of cognitive enhancers.
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2013 |
Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation.
Topics: Amphetamine; Animals; Area Under Curve; Central Nervous System Stimulants; Conditioning, Operant; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Male; Methylphenidate; Morphine; Narcotics; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward | 2014 |
Response to open peer commentaries on "prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults".
Topics: Amphetamine; Central Nervous System Stimulants; Drug and Narcotic Control; Humans; Methylphenidate; Nootropic Agents; Public Policy; Substance-Related Disorders | 2014 |
Animal model of methylphenidate's long-term memory-enhancing effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception | 2014 |
Determination of amphetamine and methylphenidate in exhaled breath of patients undergoing attention-deficit/hyperactivity disorder treatment.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Chromatography, Liquid; Exhalation; Female; Humans; Male; Mass Spectrometry; Methylphenidate; Middle Aged; Substance Abuse Detection; Ultrasonography | 2014 |
The effects of clinically relevant doses of amphetamine and methylphenidate on signal detection and DRL in rats.
Topics: Amphetamine; Animals; Attention; Central Nervous System Stimulants; Inhibition, Psychological; Male; Methylphenidate; Neuropsychological Tests; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Signal Detection, Psychological | 2014 |
Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter.
Topics: Amphetamine; Animals; Brain; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Male; Methylphenidate; Nucleus Accumbens; Rats, Sprague-Dawley; Self Administration | 2014 |
Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.
Topics: Amphetamine; Animals; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Male; Methylphenidate; Nucleus Accumbens; Rats, Sprague-Dawley; Receptors, Dopamine D2; Self Administration; Substance-Related Disorders; Time Factors | 2014 |
Responding for conditioned reinforcement in C57BL/6 and CD-1 mice, and Sprague-Dawley rats: Effects of methylphenidate and amphetamine.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Conditioning, Classical; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Motivation; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Saccharin | 2014 |
Comparing stimulant effects in youth with ADHD symptoms and epilepsy.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognition; Electroencephalography; Epilepsy; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Retrospective Studies; Severity of Illness Index | 2014 |
Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Behavior, Addictive; Central Nervous System Stimulants; Choice Behavior; Delay Discounting; Dopamine Agents; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Prefrontal Cortex; Propylamines; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Agents; Vesicular Monoamine Transport Proteins | 2014 |
Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Female; Humans; Incidence; Longitudinal Studies; Male; Methylphenidate; Middle Aged; Propylamines; Registries; Suicide; Sweden; Young Adult | 2014 |
Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.
Topics: Adolescent; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Norway; Practice Patterns, Physicians'; Propylamines; Quality of Life; Registries; Residence Characteristics | 2014 |
Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm project.
Topics: Adolescent; Algorithms; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Female; Humans; Male; Medication Adherence; Methylphenidate; Practice Guidelines as Topic; Propylamines; Treatment Outcome | 2014 |
Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
Topics: Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Medication Adherence; Mental Disorders; Methylphenidate; Propylamines; Prospective Studies; Psychiatric Status Rating Scales; Stress, Psychological; Time Factors; Young Adult | 2014 |
Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.
Topics: Amphetamine; Animals; Biological Transport; Brain; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Electrochemical Techniques; Male; Methylphenidate; Mice; Mice, Transgenic; Rats; Rats, Sprague-Dawley; Regression Analysis; Self Administration | 2015 |
Adolescent exposure to cocaine, amphetamine, and methylphenidate cross-sensitizes adults to methamphetamine with drug- and sex-specific effects.
Topics: Aging; Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Locomotion; Male; Methamphetamine; Methylphenidate; Mice; Mice, Inbred C57BL; Motor Activity; Sex Factors; Time Factors | 2015 |
The billion dollar business of being smart.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Caffeine; Central Nervous System Stimulants; Energy Drinks; Humans; Methylphenidate; United States | 2015 |
Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Dopamine; Dopamine Agents; Generalization, Psychological; Male; Methylphenidate; Modafinil; Nicotine; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Wakefulness-Promoting Agents | 2015 |
Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.
Topics: Age Factors; Amphetamine; Analysis of Variance; Animals; Animals, Newborn; Central Nervous System Stimulants; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Methylphenidate; Rats; Rats, Long-Evans; Social Isolation | 2016 |
Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Drug Therapy, Combination; Female; Guanfacine; Health Care Costs; Humans; Lisdexamfetamine Dimesylate; Male; Markov Chains; Methylphenidate; Ontario; Quality-Adjusted Life Years | 2016 |
Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
Topics: Adolescent; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Comorbidity; Female; Humans; Infant; Male; Methylphenidate; Middle Aged; Neurotic Disorders; Personality Disorders; Psychoses, Substance-Induced; Psychotic Disorders; United States; Wounds and Injuries; Young Adult | 2016 |
Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.
Topics: Amphetamine; Animals; Animals, Genetically Modified; Brain; Cocaine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Drosophila melanogaster; HEK293 Cells; Humans; Image Processing, Computer-Assisted; Locomotion; Methamphetamine; Methylphenidate; Optical Imaging; Rats; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2016 |
Intravenous Use of Prescription Psychostimulants; A Comparison of the Pattern and Subjective Experience between Different Methylphenidate Preparations, Amphetamine and Cocaine.
Topics: Administration, Intravenous; Adult; Amphetamine; Central Nervous System Stimulants; Cocaine; Cross-Sectional Studies; Delayed-Action Preparations; Drug Compounding; Euphoria; Female; Humans; Iceland; Male; Methylphenidate; Prescription Drug Misuse; Young Adult | 2016 |
Stimulant drug effects on touchscreen automated paired-associates learning (PAL) in rats.
Topics: Amphetamine; Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Conditioning, Operant; Dizocilpine Maleate; Dose-Response Relationship, Drug; Male; Methylphenidate; Modafinil; Nootropic Agents; Paired-Associate Learning; Rats; Wakefulness-Promoting Agents | 2016 |
Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Databases, Factual; Dextroamphetamine; Drug Utilization; Female; Humans; Male; Methylphenidate; Middle Aged; Psychotropic Drugs; Scandinavian and Nordic Countries; Young Adult | 2016 |
Effects of amphetamine and methylphenidate on attentional performance and impulsivity in the mouse 5-Choice Serial Reaction Time Task.
Topics: Amphetamine; Animals; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Stimulants; Choice Behavior; Impulsive Behavior; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Reaction Time | 2017 |
Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells.
Topics: Acetylcysteine; Amphetamine; Apoptosis; Carnitine; Cell Differentiation; Cell Line; Cell Survival; Cycloheximide; Dopaminergic Neurons; Dose-Response Relationship, Drug; Humans; Lethal Dose 50; Methylphenidate; p-Hydroxyamphetamine; p-Hydroxynorephedrine; Reactive Oxygen Species | 2017 |
Hemodynamic profile and behavioral characteristics during induction of anesthesia in pediatric patients with attention deficit hyperactivity disorder.
Topics: Adolescent; Amphetamine; Anesthesia; Anti-Anxiety Agents; Anxiety; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Nervous System Stimulants; Child; Child, Preschool; Female; Heart Rate; Hemodynamics; Humans; Male; Methylphenidate; Midazolam; Preoperative Care | 2017 |
Attitudes Toward Cognitive Enhancer Use Among New Zealand Tertiary Students.
Topics: Amphetamine; Benzhydryl Compounds; Central Nervous System Stimulants; Female; Health Knowledge, Attitudes, Practice; Humans; Intention; Male; Methylphenidate; Modafinil; New Zealand; Nootropic Agents; Off-Label Use; Prescription Drugs; Psychological Theory; Students; Surveys and Questionnaires; Universities; Young Adult | 2017 |
Effect of methylphenidate on visual responses in the superior colliculus in the anaesthetised rat: Role of cortical activation.
Topics: Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Male; Methylphenidate; Rats; Superior Colliculi | 2017 |
Placental Complications Associated With Psychostimulant Use in Pregnancy.
Topics: Abruptio Placentae; Adrenergic Uptake Inhibitors; Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Female; Fetal Growth Retardation; Humans; Methylphenidate; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Premature Birth; Risk Assessment; Statistics as Topic | 2017 |
Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Child; Cohort Studies; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Infant, Newborn; Methylphenidate; Middle Aged; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Risk; Risk Assessment; Scandinavian and Nordic Countries; United States; Young Adult | 2018 |
Shedding Light on the Risks of Methylphenidate and Amphetamine in Pregnancy.
Topics: Amphetamine; Cohort Studies; Dextroamphetamine; Methylphenidate; Pregnancy | 2018 |
Amphetamine, but not methylphenidate, increases ethanol intake in adolescent male, but not in female, rats.
Topics: Alcohol Drinking; Amphetamine; Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dopamine; Ethanol; Female; Humans; Male; Methylphenidate; Models, Animal; Norepinephrine; Rats; Rats, Wistar; Sex Factors | 2018 |
Pediatric ADHD Medication Exposures Reported to US Poison Control Centers.
Topics: Adolescent; Age Distribution; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Preschool; Drug Misuse; Humans; Infant; Infant, Newborn; Medication Errors; Methylphenidate; Modafinil; Patient Admission; Poison Control Centers; Retrospective Studies; Suicide, Attempted; United States; Young Adult | 2018 |
Resolution of Anxiety Symptoms in Response to Stimulants in a Patient With Attention-Deficit/Hyperactivity Disorder and Generalized Anxiety Disorder.
Topics: Adult; Amphetamine; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dextroamphetamine; Humans; Methylphenidate | 2018 |
Chronic methylphenidate treatment during adolescence has long-term effects on monoaminergic function.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dopaminergic Neurons; Dorsal Raphe Nucleus; Male; Methylphenidate; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonergic Neurons; Synaptic Transmission; Ventral Tegmental Area | 2019 |
Exposure to methylphenidate in adolescence and adulthood modulates cross-sensitization to amphetamine in adulthood in three genetically variant female rat strains.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Methylphenidate; Motor Activity; Rats, Sprague-Dawley; Species Specificity | 2019 |
Sex differences in the intensity of cross-sensitization between methylphenidate and amphetamine in adolescent rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Male; Methylphenidate; Motor Activity; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2019 |
Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Impulsive Behavior; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Neuropsychological Tests; Rodentia | 2019 |
Postmortem Brain-Blood Ratios of Amphetamine, Cocaine, Ephedrine, MDMA and Methylphenidate.
Topics: Amphetamine; Autopsy; Brain Chemistry; Calibration; Cocaine; Forensic Toxicology; Gray Matter; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Postmortem Changes; Reference Standards; Reproducibility of Results | 2019 |
Effects of amphetamine, methylphenidate, atomoxetine, and morphine in rats responding under an adjusting stop signal reaction time task.
Topics: Amphetamine; Analgesics, Opioid; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Methylphenidate; Morphine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time | 2019 |
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Topics: Adolescent; Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Databases, Factual; Female; Humans; Incidence; Insurance, Health; Male; Methylphenidate; Psychoses, Substance-Induced; United States; Young Adult | 2019 |
Psychosis during Attention Deficit-Hyperactivity Disorder Treatment with Stimulants.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Methylphenidate; Psychotic Disorders | 2019 |
ADHD medication and the inverted U-shaped curve: A pharmacological study in female mice performing the rodent Continuous Performance Test (rCPT).
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Discrimination Learning; Female; Methylphenidate; Mice; Mice, Inbred C57BL; Psychomotor Performance; Rodentia | 2020 |
Amphetamine promotes cortical Up state: Role of adrenergic receptors.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Dextroamphetamine; Dopamine; Male; Methylphenidate; Neurons; Norepinephrine; Prazosin; Prefrontal Cortex; Rats; Receptors, Adrenergic | 2021 |
The use of stimulants in depression: Results from a self-controlled register study.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Denmark; Depression; Dextroamphetamine; Drug Prescriptions; Female; Humans; Lisdexamfetamine Dimesylate; Male; Methylphenidate; Modafinil; Registries; Suicide, Attempted | 2020 |
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Drug Overdose; Female; Humans; Linear Models; Male; Methamphetamine; Methylphenidate; Michigan; N-Methyl-3,4-methylenedioxyamphetamine; Opioid-Related Disorders; Poison Control Centers | 2021 |
Sedation After a Trial of Mixed Amphetamine Salts in a Boy with Attention-Deficit/Hyperactivity Disorder.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Humans; Male; Methylphenidate; Salts | 2020 |
A Longitudinal Study of Resting-State Connectivity and Response to Psychostimulant Treatment in ADHD.
Topics: Adolescent; Amphetamine; Attention Deficit Disorder with Hyperactivity; Brain; Case-Control Studies; Central Nervous System Stimulants; Child; Female; Functional Neuroimaging; Humans; Interview, Psychological; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylphenidate; Neural Pathways; Treatment Outcome | 2021 |
The effect of methylphenidate and mixed amphetamine salts on cognitive reflection: a field study.
Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognition; Humans; Methylphenidate; Salts | 2022 |
Analysis of methylphenidate, ethylphenidate, lisdexamfetamine, and amphetamine in oral fluid by liquid chromatography-tandem mass spectrometry.
Topics: Adolescent; Amphetamine; Child; Chromatography, Liquid; Humans; Lisdexamfetamine Dimesylate; Methylphenidate; Tandem Mass Spectrometry | 2022 |
The effect of environment on cross-sensitization between methylphenidate and amphetamine in female rats.
Topics: Adenosine Monophosphate; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Female; Methylphenidate; Rats; Rats, Sprague-Dawley | 2022 |
Effects of Early Life Exposure to Sex Hormones on Neurochemical and Behavioral Responses to Psychostimulants in Adulthood: Implications in Drug Addiction.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Dopamine; Estradiol; Female; Male; Methylphenidate; Motor Activity; Nucleus Accumbens; Rats; Substance-Related Disorders; Testosterone Propionate | 2022 |
Methylphenidate cross-sensitization with amphetamine is dose dependent but not age dependent.
Topics: Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Male; Methylphenidate; Motor Activity; Rats; Rats, Sprague-Dawley | 2023 |
Theory of visual attention (TVA) applied to rats performing the 5-choice serial reaction time task: differential effects of dopaminergic and noradrenergic manipulations.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Dopamine; Humans; Methylphenidate; Norepinephrine; Phenylephrine; Rats; Reaction Time | 2023 |
Psychostimulant Drugs Activate Cell-type Specific and Topographic cFos Expression in the Lumbar Spinal Cord.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Male; Methylphenidate; Mice; Pharmaceutical Preparations; Spinal Cord | 2023 |
Reciprocal effects of single or repeated exposure to methylphenidate or sex in adult male rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Copulation; Female; Male; Methylphenidate; Rats | 2023 |
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Cross-Sectional Studies; Drug Therapy, Combination; Humans; Methylphenidate; Middle Aged; Young Adult | 2023 |
Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?
Topics: Amphetamine; Analgesics, Opioid; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cross-Sectional Studies; Heroin; Humans; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Substance-Related Disorders; Treatment Outcome | 2023 |
Evaluation and Management of Attention-Deficit/ Hyperactivity Disorder (ADHD) in Children and Adolescents.
Topics: Adolescent; Amphetamine; Attention; Attention Deficit Disorder with Hyperactivity; Child; Employment; Humans; Methylphenidate | 2023 |
Medical Cannabis Legalization: No Contribution to Rising Stimulant Rates in the USA.
Topics: Adult; Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans; Medical Marijuana; Methylphenidate; United States | 2023 |